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There is increasing interest on behalf of consumers and the food industry for the enrichment of 
common food with health-promoting bioactive molecules. Clinical studies have demonstrated that 
tangible health benefits may derive from the intake of bioactive compounds, in the prevention of 
dietary related pathologies such as diabetes, cancer, obesity and cardiovascular diseases. The 
beneficial effect is usually given by the presence in food of peculiar molecules such us carotenoids, 
polyphenols, polyunsaturated fatty acids and bioactive peptides, to cite a few. Unfortunately, these 
compounds display high susceptibility to environmental conditions such as light, extreme pH and 
temperature, and to standard food manufacturing processes. They can also account for undesirable 
flavors, colors or affect final product stability and appearance, thus rendering their presence in the 
product an issue rather than a useful addition. The addition of nutrients in small quantities into a 
food system may not significantly affect its proprieties, but the high amounts, often required to meet 
certain health claims and benefits, might bring to a product with a poorly acceptable sensory profile 
and a scarce stability. In particular, lipophilic bioactive ingredients display a major challenge. 
Besides their limited solubility in most of the foods and beverages, they are characterized by high 
susceptibility to oxidation and by a lower adsorption through the gastrointestinal tract in 
comparison to more hydrophilic substances, meaning a scanty bioavailability. Hence, there is a 
pressing need for the production of edible delivery systems or carriers that could efficiently 
encapsulate, protect and improve the handling of lipophilic molecules. 
The objective of this thesis was to develop a system suitable for the encapsulation of lipophilic 
molecules, capable of: a) protecting the ingredient from the surrounding environment (extreme pH, 
heat, UV light, oxygen); b) preserving its functionality (e.g. antioxidant activity); c) reducing the 
impact on the organoleptic level; d) improving the bioavailability of the encapsulated molecules. 
This last point in particular could be achieved by using sub-cellular delivery systems referred to as 
nanoparticles or nanocarriers, which may potentially enhance the transport across the intestinal 
wall.  
To this purpose, astaxanthin was chosen as a model bioactive compound. Astaxanthin is a keto-
carotenoid that displays several biological activities, such as high antioxidant capacity, that may 
contribute to the prevention of degenerative pathologies like diabetes, cancer, cardiovascular 
diseases and chronic bowel disease. However, like all carotenoids it is characterized by a strong 
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lipophilic character that makes its inclusion in many types of aqueous-based foods and beverages 
rather a challenge. This aspect is the main cause of its poor absorption through the human intestinal 
mucosae. Moreover, astaxanthin is labile to common processing conditions such as the presence of 
light and oxygen, extreme pH and high temperatures. For these reasons a lot of efforts have been 
put in these past years to find suitable solutions for its protection and manipulation. 
In order to develop the suitable encapsulate, in chapter 2 an emulsification and solvent-evaporation 
technique was used as encapsulation approach; whey proteins were selected as the matrix to 
envelope the core constituted by an astaxanthin-enriched oleoresin derived from Haematococcus 
pluvialis, a microalgae representing the main natural source of the carotenoid. The process was 
optimized by varying crucial parameters and the stability of the nanoparticles was tested in different 
conditions. This analysis highlighted a better performance of the encapsulated molecule in 
comparison to the starting oleoresin. Good release properties during in-vitro simulated digestion 
and the increase of the solubility in water were observed. In chapter 3, the study was focused on 
the research for plant alternative proteins as encapsulating matrices in order to satisfy the increasing 
interest of the consumers for substitutes of animal-deriving ingredients. This allowed to identify pea 
protein isolate as a valid candidate for the development of a vegetarian/vegan-allergen free 
nanocarrier. Finally, Chapter 4 dealt in depth with the antioxidant properties displayed by the 
astaxanthin nanoparticles through in vitro colorimetric assay and by the development of a cell-based 
assay. The encapsulates showed higher antioxidant capacity in comparison to the oleoresin. The 
uptake of the nanoparticles was studied in cell model systems through confocal laser microscopy 













Chapter 1. Introduction  
1. Interest of the study 
In the past years the market of functional foods and nutraceuticals have faced an exponential 
growth, due to the increasing demand of the Western society for natural products, together with the 
crescent awareness of consumers that an intimate link exists between food consumption and its 
health-beneficial effects (Link, Balaguer, & Goel, 2010; Scalbert et al., 2011;  Liu, 2013). New 
products are emerging on the market, with the aim to couple the nutritive and healthy effects of 
food consumed every day. Consequently, incorporation in foods and in nutraceutical formulations 
of bioactive compounds to improve some traits such as shelf-life, aspect or taste, avoiding the use of 
synthetic additives, as well as to give to the final products new features (e.g. antioxidant or anti-
inflammatory activity, etc.) is highly desirable for the food and food supplements industries. In 
particular, more attention is now being payed to the capacity of the products in guaranteeing the 
delivery and the bioavailability of the bioactive, limiting its impact on the sensory level. 
Encapsulation, intended as surrounding a molecule with a barrier, could be a solution to all these 
issues. In particular, nano-encapsulation, referred to the production of nanometric delivery 
encapsulated systems, is rapidly emerging as the best choice to this purpose.  Currently, the market 
of nanotechnology products in the food industry is worth about US$ 1 billion, and is based mainly 
on nanometric delivery systems for packaging coatings (Chau, Wu, & Yen, 2007). In this chapter, 
the most employed encapsulation techniques and the ways to design an encapsulate will be 
presented. 
 
1.2 The concept of encapsulation 
Encapsulation is a rapidly expanding technology with numerous potential applications in different 
areas, including food, feed, cosmetics and pharmaceuticals. Encapsulation can be defined as a 
process that leads to the entrapment of one or more substances (active agents) within a matrix (wall 
material). The encapsulated substance can be called in different manners: core, fill, payload or 
internal phase. The matrix that constitutes the wall is often called coating, membrane, shell, capsule, 
carrier material or external phase (Wandrey, Bartkowiak, & Harding, 2010; Champagne & Fustier, 
12 
 
2007; Bernard F. Gibbs Selim Kermasha, 1999; Shahidi & Han, 1993). The process of 
encapsulation could also be defined as a technology of packaging solids, liquids, or gaseous 
materials in small capsules that release their contents at controlled rates over prolonged periods of 
time and under specific environmental conditions (Desai & Park, 2005). Produced particles usually 







The terminology of encapsulation is based mainly on few terms, the knowledge of which could help 
in having a better understanding of the process: 
Active agent: The component, ingredient or nutraceutical that needs to be encapsulated within the 
delivery system. The active component can vary in chemical and/or molecular characteristics 
(charge, molecular weight, polarity and physical state) and in its functionality. Bioactive 
components that can be encapsulated include lipids, vitamins, peptides, fatty acid, antioxidants, 
minerals but also living cells such as probiotics (Burey, Bhandari, Howes, & Gidley, 2008; 
McClements, Decker, & Park, 2008). 
Delivery: The process of carrying the encapsulate material to the site of action. This may be the 
small intestine, stomach or colon if we are speaking about the human body.  
Controlled release: Refers to the process of releasing the encapsulated component with a specific 
concentration-time profile at the site of action. The release could follow different patterns:  
 Burst release: release of most of the entirety of the active agent in a short period of time. 
 Prolonged released: the active agent is released over a long period of time at a constant rate. 
An example could be the long release of sugar in a chewing gum.  
 Triggered release: the release is activated in response to a particular environmental 
component like: pH, ionic strength or the high temperature required for the release of 
encapsulated baking soda when baking a cake.  
 




1.3 The need for encapsulation 
Sixty years ago, the main sector in which encapsulation was employed was that of biotechnology, 
primarily for the separation of cells from the produced metabolites in bioreactor tanks. But 
nowadays, one of the major players along with the pharmaceutical sector, is the food industry 
(Bernard F. Gibbs Selim Kermasha, 1999). This sector is responding fast to the requirement by the 
consumers to have healthier food on the market, without losses on the sensory profile. To change 
the nutritional value and add improved features of a specific product, phytochemicals, vitamins, 
antioxidants and fatty acids need to be included into the final product. These compounds are usually 
highly susceptible to degradation by environmental factors, processing and gastrointestinal 
conditions, and therefore, encapsulation represents an approach for their effective protection 
(Nedovic, Kalusevic, Manojlovic, Levic, & Bugarski, 2011;  McClements, Decker, Park, & Weiss, 
2009). 
Apart from that, the incorporation of nutraceuticals, aromas and proteins could ameliorate the 
palatability, appearance and texture properties of the final product.  
The physical separation from the food matrix of the active compound through an inert barrier could 
avoid undesirable interactions between them (e.g. the precipitation of protein given by the presence 
of high concentration of polyphenols).  
Encapsulation could be used also to mask the taste or odor associated to the presence of the 
functional molecule (e.g. the odor of fish oil or the bitterness of polyphenol and amino acids mixes).  
The dilution of the bioactive inside the encapsulant matrix could be advantageous when it is needed 
in very small amounts.  In this way the delivery system could be guaranteed in a pre-dosed form, 
avoiding eventual toxic effects  (Desai & Park, 2005).  
The encapsulation of lipidic substances in small delivery systems soluble in water could ameliorate 
their bioavailability. As stated by the Food and Drug Administration (FDA), the term bioavailability 
refers to the rate and extent to which the active drug ingredient or therapeutic moiety is absorbed 
from a drug product and becomes available at the site of drug action  (Allam, El Gamal, & Naggar, 
2011; Fathi, Martín, & McClements, 2014). In addition to the above, encapsulation can be applied 
for modification of physical characteristics of the original material in order to allow easier handling 
and to provide an adequate concentration and uniform dispersion of the active agent.  
In particular, nanotechnology, referred to the production of encapsulate of diameter in the range of 
1-100 nm, has become one of the most promising technologies to revolutionize conventional food 
science and food industry. Nanoparticles proved their efficacy in enhancing food security, 
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extending storage life, improving flavor and nutrient delivery, allowing pathogen/toxin/pesticide 




1.4  Capsule forms 
The forms of the encapsulates generally fall in two main categories: reservoir and matrix type. The 
reservoir-type system (Fig.1.2 A) is characterized by the presence of a thick shell, an inert 
membrane that physically separates the active compound that resides in the interior part of the 




In the matrix type (Fig.1.2 B) the active agent is uniformly distributed over the formed net, 
constituted by the encapsulant material, in this way the active agent can be found also on the surface 
of the carrier that is normally called bead (Soukoulis & Bohn, 2018). Additionally, there is also a 
combination of the two forms, the reservoir-matrix system (Fig.1.2 C), where the matrix 
encapsulate is embedded by a thin membrane. This type of system is used mainly for long lasting 
release. In addition to the above, the microencapsulates can also be mononuclear with multiple 
shells/walls, and the capsules/beads may have irregular shape. 
 
1.5 Desired encapsulate characteristics 
Since food is more easily accessible to everyone in comparison to pharmaceuticals, the regulation 
about encapsulation in the food sector is much stricter (Nedovic et al., 2011). The material used for 
encapsulation needs to meet two important attributes: it has to be Generally Recognized As Safe 
(GRAS) and safe for the major governmental agencies: the European Food Safety Authority 
(EFSA) for Europe, and Food and Drug administration (FDA) for the United States. For example, 




many of the synthetic chemical polymer coatings that are used for the delivery of pharmaceutical 
products and drugs cannot be employed in designing delivery systems for food (McClements, 2015; 
Acosta, 2009).   
Other important factors that need to be considered are that the selected materials need to be:  
 Food grade: the delivery system needs to be composed of food ingredients and through a 
process that meets the legislation or cultural belief approved by the country in which the 
final product is sold (e.g. lipids, proteins, carbohydrates and water). 
 Economic feasibility: the encapsulate should be capable of being economically 
manufactured. From this requirement arises the need to search for new inexpensive 
encapsulating materials (McClements, 2015). A simple example could be the use of pectin 
(extracted from fruits peels) to produce hydrogel beads containing enriched oil of 
astaxanthin (Vakarelova et al., 2017) and flax seed oil (Menin et al., 2018).  
 Compatibility with the food matrix: the presence of the particle system should not adversely 
affect the sensory, rheological and appearance characteristics of the final product. The 
chosen material must be inert (Bernard F. Gibbs Selim Kermasha, 1999; Donsì, Sessa, 
Mediouni, Mgaidi, & Ferrari, 2011). 
 Protection against degradation: the chosen material should produce a stable and strong 
barrier against the condition that could negatively affect the functionality of the bioactive 
agent when introduced in the final product (e.g. high temperature, pH, oxygen presence etc.) 
(McClements, Decker, & Weiss, 2007). 
 Loading capacity and retention: normally the higher the amount that can be encapsulated 
for unit mass of encapsulant agent the better is. This is mainly for two reasons: 1) from the 
economic point of view it is very advantageous and 2) for the consumer the amount of 
functional food needed to reach the daily intake is reasonable. 
 Bioavailability/bioactivity: the encapsulated bioactive ingredient must be delivered and 
released at the site of action. The system should preferably enhance the absorption of the 
active, resulting in an amplification of its bioactivity (McClements et al., 2007). 
 
Since no single coating material can meet all of the criteria listed above, they are often employed in 







1.6 Nanoparticles versus microparticles 
As already mentioned, nanotechnology is defined as the production, utilization and manipulation of 
materials, devices or systems in the nanometer scale (smaller than 100 nm) (Aguilera, 2008; Fathi 
et al., 2014). Furthermore, according to the definition of the National Nanotechnology Initiative 
(NNI), it is the “understanding and control of matter at the nanoscale, at dimensions between 
roughly 1 and 100 nm, where unique phenomena enable novel applications” (Tamjidi, Shahedi, 
Varshosaz, & Nasirpour, 2013). The properties such as color, solubility, viscosity, and biological 
properties are substantially modified at a nano-scale, owing to the interactions of individual atoms 
and molecules (Neethirajan & Jayas, 2011). The major applications in food industry regards the 
packaging materials, new nutrient delivery systems and formulations with improved bioavailability 
characteristics (Weiss, Gaysinsky, Davidson, & McClements, 2009). Nanoencapsulates show long-
term kinetic stability and increased surface-to-area ratio with respect to microencapsulates, an 
aspect that potentially may enhance the solubility and the bioavailability of the active ingredient. 
For example, at sizes below 100 nm, it was shown that the particles appear to be readily adsorbed at 
the intestinal mucosa (Desai, Labhasetwar, Amidon, & Levy, 1996).  
It is important to underline that often in the scientific literature mainly dealing with food, several 
reports describe nanoparticles with sizes higher than 100 nm, which is in contrast with the definition 
given by the NNI (Sanguansri & Augustin, 2006). This is not surprising since in some cases 
particles with a diameter larger than 100 nm display features similar to those having a diameter 
below this value. Size is anyway important as it affects the optical clarity, physiochemical stability, 
encapsulation and release characteristics (Ezhilarasi, Karthik, Chhanwal, & Anandharamakrishnan, 
2013). For example, numerous studies have pointed out the importance of the size of the particle in 
relation to the transport across the mucus layer, the absorption by the epithelial cells and overall the 
fate of the particle within the human body. In general, the smaller the particle size, the higher the 
absorption of these particles through the gastro-intestinal tract (GIT). Particles larger than 300 nm 
are not directly transported into the systemic circulation (Jani, Halbert, Langridge, & Florence, 
1990), although they have been detected in the lymph and blood as they can ’leak’ through loosened 
tight junctions (Hillyer & Albrecht, 2001). 
Although nanoencapsulation is a promising technology with many advantages compared to 
microencapsulation, the number of products based on nanotechnology present on the market at the 
moment is still very limited when compared to microtechnology, mainly for three reasons: 1) the 
potential toxicity due to the small size of the delivery system, which is still elusive to both 
regulatory agencies and consumers (Bieberstein, Roosen, Marette, Blanchemanche, & 
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Vandermoere, 2013); 2) difficulty in scaling up the processes and 3) use of organic solvents, which 
are toxic, and may be present as residues in particle formulations (Müller, Mäder, & Gohla, 2000).  
 
1.7 Materials for encapsulation 
Typical ingredients for encapsulation include amorphous sugar (sucrose, lactose and trehalose), 
polyols (sorbitol and mannitol), and non-crystalline polymeric materials such as chemically 
modified starch, maltodextrin, polysaccharides (arabic, mesquite or gellan gum, alginates and 
pectins), and proteins (gelatins, whey proteins, sodium caseinate, vegetable proteins) (Wan, 
Bankston, Bechtel, & Sathivel, 2011; Soukoulis & Bohn, 2018). Common ingredients used for 




For encapsulation purposes the ideal wall material should have: good emulsifying properties, be a 
good film former, have low viscosity at high solid concentrations, low hygroscopicity, good 
property of release, low in cost, bland in taste and odor, stable in supply and able to protect the 
active ingredient (Desai & Park, 2005; Bangs & Reineccius, 1990). From the moment that none of 
the materials listed above could have all these characteristics, frequently the wall materials are used 
in combination with each other to obtain mixture of material with enhanced performance. The 
problem of working with natural ingredients or processed food ingredients is mainly the variation in 
composition and quality of the original source from which they are isolated. 
Category Materials Methods 
Carbohydrate 
Starch, maltodextrins, corn syrup solids, dextran, 
modified starch (N-lok®, Capsul®, HICAP®), 
cyclodextrin 
Spray- and freeze-drying, extrusion, 
coacervation, inclusion complexation 
Cellulose 
Carboxymethylcellulose, methyl cellulose, 
ethylcellulose, celluloseacetate-phthalate 
Coacervation, spray-drying, edible 
films, fluid bed 
Gum Gum acacia, agar, sodium alginate, carrageenan Spray-drying, ionic gelation, fluid bed 
Lipids 
Wax, paraffin, beeswax, diacylglyerols, oils, fats, 
phospholipids 
Emulsion, liposomes, film formation, 
spray chilling, fluid bed 
Protein 
Gluten, casein, zein, gelatin, albumin, peptides, whey 
protein, vegetable proteins (rice, pea, sunflower, 
chickpea etc.) 
Emulsion, spray-drying, ionic gelation, 
fluid bed 
Emulsifiers  
Mono- and di-glycerides, lecithin, liposomes, food-
grade surfactans 
Emulsion, spray dry, ionic gelation, 
Fluid bed 
Tab.1. List of encapsulating materials for food applications. 
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1.8 Encapsulation techniques 
There is a number of techniques available for encapsulation of food compounds, in which the 
processes are divided into two main categories: the mechanical/physical and the chemical ones. The 
mechanical processes involve the controlled precipitation of a polymeric solutions where a physical 
change occurs, meanwhile the chemical processes involve polymerization reactions 
(Anandharamakrishnan, 2015). The most employed technologies include spray drying, spray 
cooling/chilling, freeze drying, extrusion, fluidized bed coating, coacervation, liposome entrapment, 
inclusion complexation and emulsion (Bernard F. Gibbs Selim Kermasha, 1999; Augustin & 
Hemar, 2009;  Desai & Park, 2005). Tab.1.2 lists a series of technologies and the type of process 
they belong to. The choice of the technique to be used depends on different factors that need to be 
accurately analyzed, such as: the particle size, the appearance, physical/chemical properties of the 




Among all these techniques only a few allow to obtain particles in the nano-range. In the following 
paragraphs, these technologies will be discussed. In particular, for the aim of this thesis, only the 





Centrifugal suspension preparation 
Co-crystallization 
Emulsification 













Solvent exchange method 
Tab.1.2.  Encapsulation techniques 
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techniques indicated for the encapsulation of lipophilic ingredient will be discussed, which are a 
combination of chemical and mechanical processes. 
 
1.9 Nano delivery systems 
1.9.1 Nanoemulsions 
Nanoemulsions (NEs) are nanoscale droplets of a multiphase colloidal dispersion formed by 
dispersing two immiscible liquids through physical rupturing (Solans, Izquierdo, Nolla, Azemar, & 
Garcia-Celma, 2005; Fryd & Mason, 2012). Different size ranges of nanoemulsions are reported in 
literature: from less than 100 nm (Rao & McClements, 2011; Ghosh, Mukherjee, & 
Chandrasekaran, 2013) to 100-600 nm (Sakulku et al., 2009). Due to the size, nanoemulsions 
display interesting physical properties, that microemulsion lack. For instance, the droplet size in a 
nanoemulsion is much smaller than visible wavelength, in this way most of them appear optically 
transparent, a very favorable feature when applied to beverages. Additionally, the reduced 
dimension of NEs enhances stability against gravity, due to the Brownian motion of the nano-sized 
droplets (Fryd & Mason, 2012), avoiding deposition phenomena of the particles. NEs are also 
metastable, i.e. they can be diluted with water without changes in droplet size distribution. The 
methods used to produce NEs can be divided into mechanical and non-mechanical processes. For 
the former the most used techniques are high-pressure homogenization, microfluidization and 
ultrasonication (Villalobos-Castillejos et al., 2018; Anton & Vandamme, 2011). 
With high-pressure-homogenization, the solution is passed through a small inlet orifice at pressures 
in the range of 500-5000 psi. Microfluidization uses higher pressures, up to 20000 psi, to pass the 
liquid through microchannels (the collision chamber) where the nano-droplets are produced. The 
driving forces in the production of the droplets by these two techniques are cavitation and 
mechanical shear. The pressure applied and the number of passing cycles have a strong effect on 
particles size. 
Ultrasonication uses bubble cavitation as a mechanism of droplet formation. The ultrasound waves 
(usually in the range of 20 kHz) result in the sequential formation, growth and collapse of 
microscopic vapor bubbles in the liquid; the collapse of these cavities provides sufficient energy to 
increase the surface area of the droplets (Patil & Pandit, 2007). In this case, increasing sonication 
time is often useless because the droplet size decreases until a certain limit after which coalescence 




Nanoemulsions can also be obtained using a non-mechanical method by which organic solvents are 
used to dissolve the molecules of interest and the component is emulsified with a stabilizer 
dissolved in aqueous solution. A stabilizer is a molecule that thanks to its amphiphilic 
characteristics is able to absorb to a lipidic surface stabilizing it. The evaporation of the solvent 
leads to the stabilization of the emulsion.  
NEs are good candidates for the delivery of lipophilic or poorly water-soluble ingredients, such as 
edible oil, vitamins and carotenoids. The materials used as stabilizers are for example polysorbate, 
lecithin carbohydrate and proteins, to cite a few. 
 
1.9.2 Nanoliposomes 
Nanoliposomes (the nanometric version of a liposome), are colloidal structures formed by the input 
of energy to a right combination of constituent molecules in aqueous solution. A liposome, in 
particular, could be define as a closed, continuous, vesicular structure composed mainly by a 
phospholipids bilayer(s) in an aqueous environment (Mozafari et al., 2006; Mozafari, Khosravi-
Darani, et al., 2008). The materials used for the formation of liposomes are mainly phospholipids, 
that are also the major component of the cell membrane bilayer. The key characteristic that drives 
the process of liposome formation is the amphiphilicity, due to the presence of polar and non-polar 
regions in their structure (Mozafari, Johnson, Hatziantoniou, & Demetzos, 2008). Due to their 
biocompatibility, biodegradability and low toxicity they are widely used in the food, pharmaceutical 
and cosmetic industries. 
An important characteristic of liposomes is that they are ‘targetable’, i.e. the ability to reach a 
designated target site, and in this way deliver the molecule to a defined region (Mozafari et al., 
2006).  
In contrast to NEs, nanoliposomes can be employed not only for the encapsulation of lipophilic 
bioactive, but also for also water-soluble ones (Torchilin, 2005). The preparation procedure is 
simple: when amphiphilic molecules (dissolved in methanol, ether or chloroform) are placed in an 
aqueous system, they tend to form aggregated complexes in an attempt to cover their hydrophobic 
section, exposing their hydrophilic groups. If a sufficient amount of energy is provided to the 
aggregated structure, they can arrange themselves to form organized, closed bilayer vesicles (Lasic, 
1988; Mozafari et al., 2006). During the rearrangement process, liposomes can entrap hydrophilic 
molecules present in the aqueous solution. The energy required for liposome formation can be 
delivered through sonication, homogenization or heating. Another way to obtain nanoliposomes is 
by passing pre-formed liposomes of micrometric size through a filter-membrane with small 








A problem related to the use of liposomes is the scarce stability. During storage they can undergo 
aggregation, fusion and precipitation phenomena, this because lipid vesicles are thermodynamically 
unstable. 
 
1.9.3 Solid lipid nanoparticles 
Solid lipid nanoparticles (SLN) could be considered as an evolution of the nanoemulsion system 
(Fig.1.4). Indeed, it is possible to produce lipidic nanoparticles from nano-/micro-emulsions by 
using a lipid phase that is able to crystallize at the final temperature of application (Müller, Radtke, 
& Wissing, 2002). SLNs contain lipid droplets that are fully crystallized with the bioactive 
components being a part of the lipid matrix (Müller, Petersen, Hommoss, & Pardeike, 2007; Weiss 
et al., 2008). SLNs consist of a core of solid lipids with the bioactive being a part of the lipid 
matrix. Triacylglycerols (TAGs) are commonly used as carrier lipids. They exhibit polymorphism 
upon cooling, thus leading to different stacking of TAG molecules in different assemblies, with 
different stability. The surfactants are more or less the same used in nanoemulsion production. Two 
are the methods used for large scale production of SLNs: 1) hot homogenization and 2) cold 
homogenization (Müller et al., 2000). In the first one, the lipid mixture is melted 5-10°C above its 
melting point, the bioactive compound is added to the lipidic solution and then dispersed in aqueous 
solution containing a surfactant, at the same temperature. The obtained emulsion is then 
homogenized at controlled temperature. The result of the process is an Oil/Water emulsion. Cooling 
of the emulsion leads to the recrystallization of the lipid and the formation of solid lipid 
nanoparticles. In the second technique, the bioactive is incorporated to a melted lipid, then the lipid 
microparticles are dispersed at room temperature in a cold aqueous solution that contain a 
Fig. 1.3. Encapsulation of bioactive molecules through liposome technique. Source (Shukla et al., 2017) 
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1.10 Post processing for industrial use 
While the development and production of nanoparticles at lab-scale is well described and 
characterized, limited research integrated concurrently the post-treatment need to have a product 
scalable at the industrial level. One of the aspects is for example the concentration of nanoparticles 
that often are obtained at very low solid concentration, limiting their use in commercial applications 
and leading to high costs of transportation and storage. For example, most nanoparticle preparations 
are in the liquid form, and storage of a product in the form of a suspension or concentrate is 
detrimental for the shelf life of the product that could undergo chemical and physical instability 
phenomena. Transforming the nano-system into a powder is a suitable way to increase the stability 
of the product, the easy handling for costumers, expand the versatility of the product and reduce 
costs of storage and transportation. The chosen technique must allow the conservation of the nano-
structure and the stability of the encapsulated bioactive. In the case of dried forms of product, it is 
also necessary to have an appropriate dispersibility of the powder into native particles, without 
altering its physicochemical and biological behavior. 
In the following chapters, different techniques belonging to the microencapsulation sector will be 
discussed. These techniques due to their versatility are often use to stabilize and drying particles 
produced with other encapsulation techniques. 
 
1.11 Spray dry 
Spray-drying encapsulation has been used in the food industry since the late 1920s in the field of 
milk powder production, and it is one of the oldest processes for encapsulation of food ingredients 
(Ray, Raychaudhuri, & Chakraborty, 2016). The utilization of spray dry technology became very 
important during the 2nd World War, when the necessity for the transport of huge amounts of food 
Fig.1.4. Differences between nanoemulsion and solid-lipid nanoparticles system. 
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emerged, causing a search for new methods to reduce food volume and weight (Cal & Sollohub, 
2009).  
Nowadays, spray-drying is the most widely used microencapsulation technique in the food industry, 
typically used for the preparation of dry stable food additives. It is recognized as the cheapest 
technique to produce microencapsulated food materials (Desai & Park, 2005), due to the fact that 
the equipment is readily available and production costs are lower than most other methods 
(Gharsallaoui, Roudaut, Chambin, Voilley, & Saurel, 2007). 
Although most often considered as a dehydration process, spray-drying can be used to encapsulate 
active material within a protective matrix formed from a polymer. From a practical point of view, 
spray-drying is a unit operation by which a liquid product is atomized in a hot gas current to 
instantaneously obtain a powder. The gas generally used is air or occasionally an inert gas. The 
liquid feeding the sprayer can be a solution, an emulsion or a slurry.  
Spray-drying, depending on the starting feed material and operating conditions, produces a very 
fine powder (10–50 µm) or large size particles (2–3 mm) (Gharsallaoui et al., 2007). In most cases, 
particles produced via spray dry have a core dispersed throughout the wall material and the central 
area is occupied by an empty space resulting from expansion of particles during the drying stages 
(Reineccius, 2004). Capsules with this structure might have a core loading of 20-30% of total 
capsule weight (Thies, 2004). 
The preparation of a solution to be sprayed requires the production of a stable emulsion of the 
encapsulant and the core materials. The mixture is prepared by dispersing the active agent (often 
hydrophobic) in the solution of the polymer dissolved in water, producing an immiscible phase. The 
dispersion is then homogenized. Stability of the produced emulsion must be evaluated, to avoid 
phase separation during the atomizing step (Gharsallaoui et al., 2007; Jafari, Assadpoor, He, & 
Bhandari, 2008). Emulsion viscosity and particles size distribution of the emulsion have great 
influence on the process itself and on the final product. 
Fig. 1.5 shows the basic structure of a spray dryer. The process comprises three main phases: 1) 
atomization, 2) drying and 3) powder collection.  
1) Atomization refers to the process of simultaneous reduction of particle size. This is of great 
importance, because the formation of small drops exposes a very large surface area to the 
drying gas, therefore the heat transfer is facilitated, and the solvent evaporates within 
seconds. As a result, the drying materials never reach the inlet air temperature of the drying 
gas.  This allows the employment of spray dry technology also for the encapsulation of heat 
sensitive bioactive (e.g probiotics, flavors and polyunsaturated fatty acids) (Cal & Sollohub, 
2009).   
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Commonly used atomizer types are pressure, centrifugal and pneumatic atomizer 
(Gharsallaoui et al., 2007). The important characteristic for a spray dry atomizer is to obtain 
uniform and homogenous drops (Crosby, 1989). This has great incidence on the quality and 
stability of the final powder. 
2) Drying chamber: After atomization, the droplets are exposed to the action of a drying gas, 
usually atmospheric air. Air is directly drawn from the atmosphere, passed through a filter 
system and pre-heated (Mujumdar & Law, 2006).  
In the chamber, the dispersion droplets move in various air streams, due to non-laminar gas 
flow.                                    
 Usually, drying times are of the order of 5–100 seconds (Corrigan, 1995). However, in a 
well-designed system 15–30 seconds is a fair time for the passage of the sprayed particle 
through the drying zone (Fogler & Kleinschmidt, 1938). The most frequently used chambers 
are the vertical ones (Fig.1.3), which are characterized by a cylindrical shape that convert to 
an inverted cone at the bottom.  
Typically, the hot air inlet temperature may range from 150-220°C and evaporation occurs 
instantaneously. Consequently, the product is exposed to moderate temperatures (50-80°C), 
which mitigate the thermal degradation of the products (Cal & Sollohub, 2009; Fang & 
Bhandari, 2012).  
Due to its assets, the machine is able to select 
particles with the right dimensions. Small 
droplets < 5µm are immediately dried upon 
contact with the drying air and are 
transported with the airflow. The medium-
sized droplets have time to move out from the 
air inlet zone falling into the reversing whirl 
of the air occurring below the air inlet. The 
largest droplets escape the air whirl, and due 
to the large dimensions do not have the time 
to dry completely, thus depositing on the 
chamber wall (Southwell, Langrish, &   




Fig.1.5. Typical schematic diagram of a spray dryer: 1 Feed solution, 2 peristaltic pump, 3 nozzle cleaning 
system (in the case of pneumatic nozzle), 4 hot air system, 5 atomizer, 6 drying chamber, 7 cyclone, 8 
powder collector, 9 filter systems. 
25 
 
Particles with diameter < than 1 µm move with the exhaust air and are collected in special 
filter bags, positioned at the end of the operations unit.  
New assets of spray dry comprise multi-stage spray dryers, that allow to increase the 
resident time of the product in the air-dry flow and to decrease the drying temperature, limiting 
in this way thermal denaturation of the product and rising process effectiveness (Bimbenet, 
Jean-Jacques, Schuck, Pierre, Roignant, Michel, Brulé, Gérard, & Méjean, Serge, 2002). 
Moreover, coupling physically a spray dryer with a fluidized bed on the drier outlet side, 
allows to better control particle size and moisture content (Turchiuli et al., 2005; Cal & 
Sollohub, 2009). 
3) Powder collection: After the drying process, the particles descend towards the bottom of the 
chamber. The particles may settle on the bottom and be collected, or they may leave the 
chamber together with the outgoing air. In this case the separation takes place in cyclones or 
bag filters. Cyclones are the most used separating device (Cal & Sollohub, 2009). They 
consist of an upper cylindrical part, referred to as the barrel, and a lower conical part, 
referred to as the cone. The gas stream, loaded with solid particles, leaving the spray dryer 
enters tangentially at the top of the barrel and travels downward into the cone, forming an 
outer vortex. The increasing air velocity in the outer vortex exerts a centrifugal force on the 
particles, separating them from the gas stream. When the gas stream reaches the bottom of 
the cone, an inner vortex is created, thus reversing its direction and exiting out at the top as 
clean gas. The particulates fall into the collection chamber attached to the bottom of the 
cyclone (Anandharamakrishnan, 2015).  
 
Particle shape is an index of many parameters such as particle size distribution, flowability, 
friability, bulk and particle density.  
The interaction between variables such as inlet and outlet temperature, flow rate of drying gas, the 
feed properties (such as concentration, solute diffusion coefficient and solvent latent heat), govern 
the final particle morphology, which can be that of a hollow particle or of a solid spherical particle. 
Fig 1.6 shows different scanning electron microscope (SEM) pictures of particles obtained by spray 
dry technology representing different morphologies.   
In spray dry process, significant parameters that need to be carefully evaluated are: inlet 
temperature and feed rate which coupled give control over the drying rate of the particles and final 
water content of the product (Anandharamakrishnan, 2015). The feed rate depends on the viscosity 
and surface tension of the feeding solution: solutions with low viscosity are atomized with a higher 







The outlet temperature is a parameter that cannot be directly controlled, because it depends on the 
drying characteristic of the material used. It is the highest temperature to which the product may be 
heated (Cal & Sollohub, 2009).  Ideal temperatures of the final product have been identified to be in 
the range of 50-80°C in order to avoid thermal degradation of thermo-degradable products. The 
drying air flow, if possible need to be adjusted to the maximum permitted in order to maximize 
operation efficiency of the cyclone (Maury, Murphy, Kumar, Shi, & Lee, 2005). 
Because of the complexity of the various spray-drying steps, spray-drier procedures have been 
traditionally based on experience, trial-and-error, and pilot scale work. The advantage of this 
technique is that it is economical, flexible and continuous. It can produce particles of good quality 
with diameters of less than 40 µm, a dimension that could leave the final product unaltered on a 
textural and sensorial perspective (Crosby, 1989; Anandharamakrishnan, 2015). 
The main limitation of the spray-drying technique in microencapsulation is the limited number of 
wall materials available, which must have a good solubility in water. Another disadvantage of 
spray-drying that should be considered is that it produces a fine powder which needs further 











Fig. 1.6 Different morphology patterns of spray dried particles. (A) Smooth surface (B) Blow‐hole formation (C) 
Agglomerate (D) Dented surface. From: (B and D) Rajam et al., 2012. (A and C) Ezhilarasi et al., 2013. 
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1.12 Spray chilling/cooling  
This is a technology in which the opposite principle of the spray drying is applied, i.e. the process 
of solidifying an atomized solution in particles.  As in spray drying, the three main phases consist 
in:  1) atomization, 2) particles formation and 3) collection of the particles. The primary difference 
is given by the particles formation zone, where the particles are formed from the cooling and 
hardening, and not as a consequence of solvent evaporation (McClements, 2015).  The second one, 
is the nature of the carrier material used primarily constituted by lipids deriving from vegetable oil 
with melting point in the range of 45-122°C (fats and stearins) and 45-67°C (mono and di-
glycerides) (Anandharamakrishnan, 2015).  
The feed preparation starts with the dispersion of the active material in the matrix solution. The 
basic process consists in the feed of a slurry or a homogenous mixture of the active ingredient and 
the matrix encapsulant into a nozzle system. The nozzle atomizes the mixture into a chamber where 
the droplets are cooled or gelled into particles. The formed particles are then collected through a 
cyclone, electrostatic collector, liquid hardening bath, powdered beds or filter bag system 
depending on the machine design.  Particles solidification takes place in the cooling chamber, this 
process is dependent from the cooling chamber characteristics and material properties. The cooling 
chamber needs to maintain a temperature below the melting point of the solid during the entire 
atomization process. Different methods of droplet formations are available, but the most common is 
the spray-atomization one. This system (showed in Fig.1.7) ranges in capacity from less than 1kg/hr 
to tons/hr. The particle size of the final products could go from 40-100µm, depending on the type of 
atomization unit used.  
Spray chilling requires to use ingredients for encapsulation that will solidify when atomized in the 
presence of low temperatures (Desai & Park, 2005). The two most common categories of material 
used with spray chilling are melts and gels. Melts are composed of a molten matrix material, such 
as wax or fat (e.g polyethylene glycol, bees wax, palmitic and stearic acid, carnauba and candellia 
wax, shellac). An advantage derived from the use of these materials, is that since there is no need 
for evaporation, the production rate is equivalent to the feed, assuming 100% recovery of the 
atomized material. Gels are composed of matrix material dissolved in water (e.g gelatin, 
carrageenan, agar, gellan gum, pectin and alginate). Differently from melts, gels often need to be 
dried after collection to remove water. 
The main disadvantage of this techniques is represented from the fact that most of the 









1.13 Fluid bed 
Fluid bed was originally developed as a pharmaceutical technique, but it is now increasingly 
applied in the food industry (Desai & Park, 2005; Shilton, & Niranjan, 1993).  
Fluidized bed was first developed in the 1950 by Dale E. Wuster, to encapsulate tablet with sugar 
for medical purpose (Dixit & Puthli, 2009). Today, this method is widely employed because thanks 
to the different assets of the machine it can be employed for freezing and cooling, drying, puffing, 
freeze-drying, spray-drying, coating, agglomeration and granulation.  
The machine is basically composed by four major components showed in Fig.1.8: 1) an air handling 
system; 2) a product container; 3) an expansion chamber and 4) an exhaust system to retain particles 
within the processing chamber (Burggraeve, Monteyne, Vervaet, Remon, & Beer, 2013).  
Fluidized bed technology is based on the separation of particles in a gas stream. The operating 
principle of fluidized systems is based on the fact that if a gas is allowed to flow through a bed of 
particulate solids at velocities greater than the settling velocity of the particles, the solids become 
suspended in the stream of upward moving gas (Dixit & Puthli, 2009). The gas stream negates the 
gravitational pull due to the weight of particles enabling the suspended state of the solid. The 
definition “fluid bed” describes the behavior of the solid particles that act like a fluid (McClements, 
2015).  
Fig. 1.7 Spray chilling schematic diagram: 1) Drying air; 2) hot/warm feed system; 3) nozzle system; 4) drying 
chamber; 5) cyclone; 6) powder collector; 7) filter bag system. 
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The machine design is classified according to the spray direction of the feeding solution from the 
nozzle (Fig.1.8) as:  
A) Bottom/Wuster spray (Fig.1.8 A): the nozzle is positioned at the base of the chamber, in the 
middle of the distributor plate, and liquid is sprayed in the same direction of the fluidizing 
air. 
B) Top spray (Fig.1.8 B): the binder liquid is sprayed from the top down onto the fluidized bed, 
counter-currently to the fluidizing air.   
C) Tangential spray (Fig 1.8 C): the nozzle is introduced at the side of the chamber, embedded 
in the powder bed during granulation. 
The nozzle is used to facilitate the dispersion of a liquid into spray of small droplets. The most 
popular energy source for the nozzle is compressed gas.  Of fundamental importance is the choice 
of the right amount of liquid and the volume of atomizing air used to produce the droplets, in order 
to obtain a final product with the desired characteristics. As a consequence of the modification of 
these two parameters the final product can be classified as a raspberry structure, an agglomerate or 
granules.   
As a simple rule, larger particles will be better coated with a relatively low atomization air pressure, 
giving slightly larger particles as a final product. Larger droplet size can cause agglomeration 
between the particles, this could be an unwanted characteristic due to the risk of separation of the 
agglomerate in a later stage in the process (Schaafsma, Kossen, Mos, Blauw, & Hoffmann, 1999).  
Fluid bed machines require a large volume of air to maintain the particles suspended in the air. In 
order to avoid the blow out of the particles, filters are an unavoidable part of the equipment. They 
are made of textile and the pores are large enough to permit the passage of the air, but small enough 
to retain the particles. The filter can also be composed of stainless steel and Teflon.  
From the encapsulation point of view, in this technology the bioactive food, in the form of powder, 
is suspended in an air flow and the matrix components are sprayed onto the bioactive components. 




In particular, granulation process via fluid bed, applied to enhance wettability and flowability 
properties of powder is the most important application of fluid bed. It requires the suspension of 
particles in a conical shaped container by the use of a (heated) air stream.  The applied air velocity 
should allow proper particle movement in the container but keep the material out of the filter bags 
(Fig. 1.8.  Good fluidization can be visually monitored by the free downward flow of the granules at 
the windows of the container.  
                       
As particles move up and down in the container, a binder solution is sprayed.  Binder liquid droplets 
are deposited onto the fluidized particles in the spray granulation zone. After spraying the required 
amount of binder liquid, further fluidization enables rapid drying of the particles.  Drying reduces 
the residual moisture of the granules to a level that ensures the stability of the final product.  A good 
granulation is achieved when particles are uniformly mixed and liquid bridges between the particles 
are strong and easy to dry.  
In food industry this technology gives the opportunity to deposit a multi or single layer of 
encapsulant matrix on powdered ingredients. The deposition of the layers can present different 
features: protection, target release, avoid the stickiness of the product during storage, taste and odor 
masking. This technology gives also the opportunity to increase the particle size of fine powder 
through agglomeration, a process in which primary particles are joined together so that bigger 
porous secondary particles (conglomerates) are formed (Palzer, 2005). 
Fig. 1.8. Fluid bed schematic diagram: 1) Process air inlet; 2) coating chamber; 3) expansion chamber; 4) filters 
system; 5) air outlet; 6) pulse air; in the right part is represented the machine design referred to the nozzle position: 
A) bottom/Wuster spray, B) top spray and C) tangential spray. 
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Nowadays, this process is widely used to obtain instant powder, which that are quickly dispersible 
with minimum stirring (Freudig, Hogekamp, & Schubert, 1999). The materials used for coating are 
mainly water-soluble biopolymers, lipids, proteins, gums,  carboxymethylcellulose, sodium 
alginate, pectin, kappa-carrageenan, gelatin and starch hydrolysates (Dewettinck & Huyghebaert, 
1999; Meiners, 2012) .   
The main advantage of this technique is the possibility to increase the size of fine powder, with an 
improvement in the handling, wettability, flowability and compressibility. The disadvantages are 
the low yield and scarce uniformity of the final product (Liske, & Mobus, 1968).  
 
1.14 Freeze drying 
This technology involves the crystallization of a solution or suspension at low temperature, 
followed by its sublimation from the solid state directly into the vapor phase (Liu, Zhao, & Feng, 
2008). This technique comprises three main stages: 1) freezing, 2) primary drying and 3) secondary 
drying. In the first stage the sample is crystallized to ice at sub-zero temperatures. The primary 
drying involves the sublimation of the crystal ice formed during the first step. Sublimation is an 
endothermic process that takes place at low values of pressure and temperature. This process leaves 
in the lyophilized structures pores, that gives to the product excellent rehydration ability. The 
secondary drying is related to the desorption of unfrozen water at a comparatively higher 
temperature than that of primary drying.  
As an encapsulation technique, the core and wall are dissolved and then dispersed in water. The 
solution is then frozen and dried under low pressure conditions. The result is a slab of dried product 
which is flaky in shape.  
The particle size of the encapsulates after freeze drying is in the range of 20–5000 µm, and the 
structure is of the matrix type (Zuidam & Shimoni, 2010).  
This technique is used also in order to stabilize and dry particles obtained with other techniques 
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Chapter 2.  
 
Preparation and stability evaluation of astaxanthin-
containing protein-based nanoparticles  
 
Abstract  
Astaxanthin (3,3’ dihydroxy-β,β-carotene-4,4’dione) (ASX) is a carotenoid of industrial and 
commercial interest due to its potential health benefits but its use in the food, feed and 
pharmaceutical fields is limited due to low bioavailability, scarce stability to thermo-chemical 
treatments, susceptibility to oxidation, and poor organoleptic characteristics. The aim of this work 
was to develop a method to stabilize astaxanthin from Haematococcus pluvialis oleoresin and to 
improve its bioavailability through nano-encapsulation. Nano-particles (NPs) were produced by 
emulsion solvent-evaporation technique using whey proteins concentrate (WPC) as stabilizer. The 
efficacy of encapsulation was 96%. The particle size was found to be in the range of 80-130 nm. 
Superficial charge of the capsules was negative. The shelf-life of the NPs was investigated by an 
accelerated system. Encapsulated ASX was found to be more stable to chemical and light stresses in 
comparison to the starting oleoresin. A simulated gastro-enteric digestion was conducted to study 
the release in physiological conditions. This showed that the bioaccessibility of astaxanthin was 
93%. The data collected suggest that WPC ASX NPs might have possible future applications as 
supplements for human and animal diets. 







Free radicals and oxidative stress are acknowledged to cause damages to important biomolecules 
such DNA, lipids and proteins and for this reason they are correlated to cancer, cardiovascular 
disease, diabetes, autoimmune and neurological disorders (Surh, 2003). There is an increasing 
knowledge given by scientific, clinical and epidemiological data of a direct link between the daily 
assumption of antioxidants, such as carotenoids and polyphenols, and a lowering effect of such 
diseases (Nishino et al., 2002). Astaxanthin (ASX) (3,3’-dihydroxy-β-β’-carotene-4,4’-dione) is a 
symmetric ketocarotenoid widely distributed in nature, responsible for the bright red to pink color 
of some crustaceans, salmons and birds. The major natural source of ASX is Haematococcus 
pluvialis (H.p.) a freshwater algae which under stress condition can accumulate 2-5.3% of ASX on 
the dry weight (Ambati, Siew Moi, Ravi, & Aswathanarayana, 2014; Poonkum, Powtongsook, & 
Pavasant, 2015). This molecule attracted the interest of the scientific community thanks to its well-
known antioxidant capacity, estimated as 10 times greater than other carotenoids, including lutein 
and β-carotene, and as 100 times higher than alpha tocopherol (Higuera-Ciapara, Félix-Valenzuela, 
& Goycoolea, 2006; Naguib, 2000; Kobayashi & Sakamoto, 1999). It has been proved to be 
effective against diabetes, cardio-vascular disease, some type of cancers, gastric ulcers and in skin 
protection against UV rays (Guerra & Otton, 2011; Pashkow, Watumull, & Campbell, 2008; Nakao 
et al., 2010).  
The enrichment of food with ASX is limited due to the high instability of the carotenoid to light, 
high temperatures and extreme pH due to its conjugated structure (Martínez-Delgado, Khandual, & 
Villanueva–Rodríguez, 2017; Kittikaiwan, Powthongsook, Pavasant, & Shotipruk, 2007). In 
addition, the strong lipophilic nature of ASX underlies its scarce bioavailability (Anarjan, Tan, 
Nehdi, & Ling, 2012).  
ASX is commercially available mainly in the forms of ASX oleoresin and H.p. aplanospores. H.p. 
oleoresin, is a dense oil, very difficult to manipulate due to the high insolubility in water. 
Furthermore, it does not meet the consumer perception due to the algae-related taste and smell. 
Aplanospores represent the H.p. growth stage in which ASX accumulation reaches the maximum 
yield. These cells are collected, dried, physically broken and used directly as a supplement. It is 
important to underline that aplanospores are characterized by three walls made of sporopollenin and 
algenan (Hong et al., 2018;Huang, Liu, Sun, Xue, & Mao, 2018) that act as a natural barrier against 
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oxidation and chemical attack (Mendes-Pinto, Raposo, Bowen, Young, & Morais, 2001) but also as 
an obstacle for human digestive enzymes (Krichnavaruk, Shotipruk, Goto, & Pavasant, 2008).  
Different technologies have been employed to reduce ASX degradation and to increase its 
bioavailability. These include the encapsulation by different approaches using a number of shell 
materials (chitosan, alginate, pectins, maltodextrin etc. (Vakarelova et al., 2017; Kittikaiwan et al., 
2007) but these structures are sometimes difficult to be digested due to the lack of specific enzymes. 
In some other cases the micrometer range of the obtained capsules require a mechanical disruption 
to release ASX. Another approach employed is represented by solid lipid nanoparticles (SLN) 
(Tamjidi, Shahedi, Varshosaz, & Nasirpour, 2017; Li, Zahi, Yuan, Tian, & Liang, 2016) but this 
system sufferes thermal instability due to the relatively low melting point of the fats employed, that 
does not allow the inclusion of SLNs in cooked or pasteurized products. In another work chitosan 
was used to protect ASX against oxidation with great success (Higuera-Ciapara, Felix-Valenzuela, 
Goycoolea, & Argüelles-Monal, 2004; Kittikaiwan et al., 2007) , but the insolubility in water and at 
neutral pH of chitosan, and its scarce release properties render this solution not suitable for many 
food applications.  
Besides improving the stability of active molecules, nanoencapsulation represents a strategy to 
improve also their bioavailability. Indeed, the incorporation of ASX and other carotenoids in 
colloidal systems with dimensions close to 100 nm could improve the cell uptake of compounds 
with a bioavailability inversely proportional to the diameter of the nanostructure (Anarjan & Tan, 
2013; Anarjan et al., 2012; Salvia-Trujillo, Qian, Martín-Belloso, & McClements, 2013).  
In the present work whey proteins, a generally recognize as safe (GRAS) material with high 
nutritional value, have been employed as a carrier to produce a water-dispersible ASX formulation 
particularly suitable for human consumption. The incorporation of carotenoids in a nanocarrier 
poses relevant stability issues. Indeed, in comparison to a microencapsulated form, the higher 
surface/volume ratio typical of nanocarriers can promote oxidation (Britton, 1995). For this reason, 
NPs stability was assessed in different conditions of pH, in presence of oxidant species, and upon 
UV light and heat treatment. The release of ASX in al conditions and the bioaccessibility were 






2. Materials and methods 
 
2.1. Chemical and reagents 
Whey protein concentrate (WPC) 80 was gently provided by I.T.ALI. (Reggio-Emilia, Italy). The 
protein content was 80% (w/w). Haematococcus pluvialis powder was obtained from a local 
supplier. Ethyl acetate, acetone HPLC-grade, pepsin, pancreatin, trypsin, sodium cholate were 
purchased from Sigma-Aldrich (St. Louis, MO, USA).  
 
2.2.  Astaxanthin extraction from H.p.  
H.p. oleoresin was obtained using the protocol proposed by Bustos-Garza and co-workers with 
minor modifications (Bustos-Garza, Yáñez-Fernández, & Barragán-Huerta, 2013). Briefly, the 
algae powder were pretreated by mixing 5 g of algae and 1 ml of 3 M HCl and treating the sample 
in a microwave oven for 1 min at 100 W (Sarada, Vidhyavathi, Usha, & Ravishankar, 2006). The 
pretreated algae were extracted with 25 ml of ethyl acetate in a tube with a screw cap, for 60 min 
under agitation at 50 °C in a thermal bath. The solid portion was separated by centrifugation at 3000 
g for 10 min to eliminate the biomass. The oleoresin was kept in the dark at 4 °C until use. 
 
2.3.  Spectrophotometric analysis 
2.3.1.    ASX quantification 
Quantification of ASX was performed using a UV/VIS spectrophotometer (Unicam UV2). The 
samples were diluted in ethyl acetate and the absorbance measured at 480 nm. The concentration of 
ASX was calculated following the equation: 
  
Where [A] is the concentration of ASX expressed as mg/ml; A480 the sample’s absorbance at 480 
nm; DF: dilution factor; E(1%;1cm): ASX percent solution extinction coefficient [(g/100 ml)-1 cm-1] in 




      2.3.2.   Turbidity analysis 
Turbidimetric analysis was performed by monitoring the absorbance at 660 nm (Tang, Wang, Yang 
& Li, 2009). 
 
2.4.  HPLC analysis 
Reverse phase HPLC of astaxanthin-containing samples was performed with a Beckman System 
Gold (Beckman Coulter) on a C30 column (4.6 x 250 mm, particle size 5 µm) (YMC Europe, 
Schermbeck, Germany) following a previously described method (Reyes, Mendiola, Ibanez, & del 
Valle, 2014) with minor modifications. The absorbance was monitored at 480 nm by a Beckman 
168 diode array detector. The injection volume was 50 µl. The elution was carried out at a flow rate 
of 1 ml/min using acetone (solvent A) and water (solvent B) as follows: isocratic elution at 84:16 
(A:B) for 10 min and a gradient to 97:3 (A:B) for 100 min. 
 
2.5.  Astaxanthin nanoparticles preparation 
Astaxanthin nanoparticles (ASX NPs) were produced following the method described previously by 
(Yi, Lam, Yokoyama, Cheng, & Zhong, 2015) with some modifications. WPC was dissolved in 
distilled water in a concentration range between 1 and 10%. The solution was stirred for 30 minutes 
at room temperature. H.p. extract was differently diluted in ethyl acetate and combined with the 
protein solution at a ratio of 9:1 (protein solution:oleoresin). A fine emulsion was produced using 
an ultra-sonicator for 10 minutes at a potency of 10 W (Microson ultrasonic cell distruptor XL). At 
the end of the process ethyl acetate was removed using a nitrogen flow in the dark. The WPC ASX 
NPs were kept in the dark at 4 °C until use. (Different methods, e.g use of high shear homogenizer, 
sonicator and combination of them, intensity and times were evaluated as well for the production of 
ASX NPs). 
 
2.6. Characterization of astaxanthin nanoparticles 
2.6.1. Surface charge and average diameter  
Zeta-potential, mean diameter and polydispersity index (PDI) of WPC-ASX nanoparticles were 
analyzed by dynamic light scattering principles using a Malvern Zetasizer (Nano-ZS; Malvern 
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Instruments, Worcestershire, U.K). Prior the analysis the sample were diluted 80 times to avoid 
multiple scattering effect. PDI value ranging from 0 to 1, indicated the distributions of the particle 
sizes, value close to 0 indicated a uniform population of particles and a value close to 1 indicated a 
wide variety of dimensions among particles size distribution. Zeta potential give an important 
information about particles stability, for values closer to 0 the system is considered not stable, due 
to the absence of a net charge that can contrast the aggregation process of NPs.  
 
2.6.2.  Encapsulation efficiency  
WPC ASX NPs were treated enzymatically with 2 mg/ml of trypsin for 4 h at 37°C in a thermo-
shaker (Biosan, Riga,  Latvia). The enzymatically digested solution was mixed with a double 
volume of ethyl acetate and placed on a rotating shaker for 60 minutes. The solution was 
centrifuged at 12,000 g for 5 minutes to allow the separation of the two immiscible phases. ASX 
was recovered from the upper phase, diluted opportunely and quantified by spectrophotometry as 
described above. The efficiency of encapsulation was estimated by the subsequent formula:  
Encapsulation Efficiency %= (ASXf/ASXi)*100 
Where ASXi represents the initial amount of ASX loaded in the NPs, whereas ASXf refers to the 
amount of ASX recovered from NPs after the breakage of the protein shell via enzymatic extraction.  
 
2.6.3.  Chemical stability  
The chemical stability of ASX NPs was tested in solutions with different pH values (1-10) adjusted 
using NaOH or HCl solutions. The stability was evaluated using a UV/VIS spectrophotometer 
(Unicam UV2) reading the absorbance at 650 nm as a turbidimetry index. 
 
2.6.4.  Oxidation stability 
Stability of WPC ASX NPs and ASX from H.p. extract against chemical oxidation was analyzed 
according to the method proposed by Pan and co-workers (Pan, Yao, & Jiang, 2007) with some 
modifications. Briefly, the H.p. oleoresin was solubilized in Dimethyl sulfoxide (DMSO) and 
diluted in water to reach a final concentration of 7.5 µg/ml. The samples (980 µl) were mixed with 
10 µl of a FeCl3 solution (350 µg/ml) and incubated at room temperature for 24 hours. At different 
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time points: 20, 60, 180 and 1440 min. , an aliquot of the solution was analyzed and the % of ASX 
retained evaluated. The % of residual ASX from NPs was analyzed through enzymatic digestion 
with trypsin as previously described. The sample containing H.p. oleoresin was directly extracted in 
a double volume of ethyl acetate. Prior the extraction a solution of ascorbic acid (10 µl from a 1.3 
mg/ml stock solution) was added to the sample in order to stop the oxidative reaction.  
The % of ASX retained was evaluated using the following equation: 
ASX % = (ASXr/ASXi) *100 
where ASXr corresponds to the amount of ASX retained after the exposure to the oxidation 
condition and ASXi is the initial amount of ASX determined through enzymatic extraction after 
encapsulation process. 
 
2.6.5.  UV stability 
The stability against UV-B light of WPC ASX NPs and H.p. oleoresin (solubilized in DMSO as 
described above) was studied using a trans-illuminator (Bio-Rad, Hercules, CA, USA). During the 
exposure aliquots of the samples were taken at different time points: 5, 30, 60 and 120 min. . The % 
of residual ASX was determined by spectrophotometry as previously described.  
 
2.6.6.  Storage stability 
Storage stability of WPC ASX NPs and H.p. oleoresin was evaluated at 65°C. The samples were 
kept in a static oven (Memmert, Germany) in a closed tube. To study the stability of the H.p. 
oleoresin, ethyl acetate was removed to obtain only the oleoresin from H.p. At different time points 
the samples were analyzed for the content of residual ASX by spectrophotometry and an HPLC 
analyses were performed. 
 
2.6.7.  Simulated in vitro digestion 
In vitro digestion was performed following Infogest protocol (Minekus, Alminger, Alvito, Ballance, 
Bohn, Bourlieu  & Dufour, 2014). Simulated gastric fluids (SGF) and Simulated Intestinal Fluid 
(SIF) were prepared following the protocol. The duration of the two phases were 1 h for the gastric 
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and 4 h for the intestinal phase. The enzymes used were porcine pepsin and pancreatin for the 
gastric phase (pH 3) and the intestinal phase (pH 7) respectively. Bile salt in the form of sodium 
cholate was added to SIF to a final concentration of 10 mM. Briefly, NPs and SGF were mixed in a 
ratio 1:1, the pH was eventually adjusted to 3 with HCl 1M. After 1 hour, SIF was added in a ratio 
1:1 and the pH adjusted to 7 with NaOH 1M. The reaction was conducted at 37°C in a rotating 
shaker. Every 30 min. samples were extracted with a double volume of ethyl acetate. The amount of 
ASX released from WPC ASX NPs were evaluated by spectrophotometry. De-esterification degree 
was evaluated through HPLC analysis. 
2.7.  Statistical analysis 
All measurements were performed in triplicate and the results were reported as mean value ± 










3.  Results and discussion 
 
3.1.  Physical evaluation of WPC ASX NPS 
ASX was extracted from H.p. cells with a maximum yield of 1.1% w/w. HPLC analysis of the 
oleoresin was performed to understand if the microwave-assisted extraction and the thermal 
treatment at 50°C could have detrimental effects on ASX integrity. The HPLC profile showed the 
presence of ASX mainly in the mono-esterified form (80%), followed by the di-esterified form 
(18%) and a low amount of free form (2%). Traces of other carotenoids were observed but not 
quantified. This result, reflects with minor differences the ones found in literature (Rao, Sarada, & 
Ravishankar, 2007) regarding H.p. oleoresin. 
WPC was employed as a biocompatible matrix to improve the bioavailability and dispersibility of 
ASX in water through emulsification-solvent evaporation technique. The process was optimized 
considering two parameters. The first parameter considered was WPC concentration. As reported 
earlier (Yi, Lam, Yokoyama, Cheng, & Zhong, 2014) the amount of the matrix material can 
influence not only the dimension of the NPs, because of the layering effect of the proteins that tend 
to form growing structures until a stable conformation is reach, but also the time requested to 
release the bioactive compound during digestion process. 
The solution containing ASX NPs was transparent with a red-orange bright color (Fig. 4), but the 
increasing concentration of protein led to a loss of transparency as demonstrated by the increase of 
the absorbance registered at 660 nm (Fig.1).  
 
 




The average size, PDI and zeta potential were considered as reference parameters to evaluate the 
process. As shown in Fig.2 A, the increase of proteins amount led to an increase of the dimensions 
of ASX NPs from an average size of 90 nm, obtained with the lowest concentration, to 128 nm with 
10% WPC. The data showed an evident dependency of the dimensions from protein concentration. 
PDI values were low for all the formulations, indicating a homogeneous size NPs population, but no 
statistically significant differences were observed among the samples. Zeta potential values were 
highly negative (Fig.2 B), due to the WPC shell that at neutral pH are negatively charged. Values 
higher than +20 and less than -20 are normally associated to stable NPs (DeLuca, Kaszuba, & 
Mattison, 2006). This is because of strong repulsive forces that inhibit the aggregation phenomena. 
What we observed was a decrease of zeta potential value by increasing the % of WPC: the 10% 
preparation showed a zeta potential of -17.0 ± 4. Although the best values of zeta average, PDI and 
zeta potential were obtained with WPC concentration ranging from 0.1 to 1%, a rapid degradation 
of ASX was experienced at WPC concentrations from 0.1% to 0.5%. As a consequence, the 










The second parameter considered was the amount of H.p. oleoresin used. As shown in Fig.3 (A), 
the diameter of ASX NPs decreases with the increase of oleoresin, reaching a minimum of 95 nm. 
This sample showed a surface charge higher than -20 mV (-17.9 ± 4.56 mV) (Fig.3 (B)), 
underlining the instability of the structure. This is possibly due to the high amount of oleoresin 
exceeding the amount of proteins constituting the shell. Also, in this case the PDI value were low 








Fig. 2. Variation of size and PDI (A) and z-potential (B) as a consequence of the protein concentration used to 










Satisfactory results were given by the NPs made with 4.5% of H.p. oleoresin with a Z-average of 
102.7 ± 0.36, PDI of 0.242 ± 0.016 and a surface charge of -28.5 ± 6.5. 
Fig.3. Variation of size and PDI (A) and z-potential (B) as a consequence of the different H.p. oleoresin 
concentrations used to produce ASX WPC NPs. Differences between values indicated by the same letter are 










A comparison between the absorption spectra of H.p. oleoresin in ethyl acetate and WPC ASX NPs 
in water revealed a small shift of the maximum absorption of ASX from 480 nm to 470 nm after 
encapsulation process. This might be due to the presence of the protein shell together with the fact 
that the solvent is necessarily different. In the case of WPC ASX NPs, a great absorption at 




Fig.5. Comparison between the absorption spectra of the H.p. oleoresin and WPC ASX NPs. 
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wavelengths <300 nm given by the presence of proteins was detected. On the whole the absorption 
characteristics of encapsulated astaxanthin in the visible spectrum are conserved.  
The encapsulation efficiency was 96 ± 2.5%. The minor loss of ASX could be caused by the 
oxidation generated from the sonication process, or from the incomplete degradation of the protein 
shell during the enzymatic extraction. HPLC analysis of the extract from WPC ASX NPs was 
performed and compared to the one of the H.p. oleoresin before the encapsulation process (Fig.6). 
No qualitative differences were observed, indicating that encapsulation process did not affect the 
nature of the esters distribution. It could be interesting to evaluate if the process leads to the 
formation of cis isomers by a different chromatographic approach. The biological activity of these 








Fig.6. HPLC chromatograms of H.p. oleoresin composition showing free, mono-esters and di-esters of ASX 
before and after encapsulation. 
53 
 
3.2.  Characterization of WPC ASX NPs 
3.2.1.  pH stability 
WPC ASX NPs stability was analyzed at different pH values. NPs were found unstable at pH 
between 3,5 and 5,5, giving the formation of aggregates that tend to precipitate. The pH range 
corresponds to the average isoelectric point of the shell proteins. Qian and co-workers (2012) 
reported that the aggregation of protein-stabilized nano-emulsions might originate from the small 
net surface charge registered at pH close to the pI of proteins, not sufficient to exert electrostatic 
repulsion among the particles (Qian, Decker, Xiao, & McClements, 2012). 
 
3.2.2.  UV degradation 
As already reported, one of the major factors responsible for the degradation of ASX is light 
(Vakarelova et al., 2017). It is also acknowledged that ASX could function as a protective agent for 
human skin against UV rays (Rao et al., 2013). Given the importance of this aspect we decided to 
analyze the behavior of WPC NPs ASX formulation in comparison to that of H.p. oleoresin exposed 
to direct UV light. As shown in Fig.7, after two hours of exposure to UVB light the ASX % 
retained in WPC ASX NPs and in H.p. oleoresin was 70.5% and 4.1% respectively.  
 
 
Fig. 7. Comparison between ASX retained in the WPI ASX NPs and H.p. oleoresin after exposure to UV rays. 
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This result shows that the protein shell could exert a protective effect towards the ASX contained in 
the NPs. The initial degradation of ASX from WPC ASX NPs could derive from the oxidation of 
the ASX exposed in the outer layer of the NPs, indeed this effect seems to reach a plateau after 1 hr 
of exposure to UV light.  
 
3.2.3. Chemical degradation 
Another factor that could affect the stability of ASX is the presence of oxidant species, i.e. iron, that 
is ubiquitous in food products and known as a harsh oxidizer. The physical barrier represented by 
the WPC shell and its intrinsic capacity to chelate metal ions could influence the stability of ASX 
contained in NPs (Boon, McClements, Weiss, & Decker, 2010; Woodall, Lee, Weesie, Jackson, & 
Britton, 1997). To this purpose ferric chloride (FeCl3) is commonly used as an oxidizing agent for 
studying carotenoid stability (Boon et al., 2010). The results reported in Fig.8 underline a different 
behavior between the samples: the H.p. oleoresin showed a pattern characterized by a rapid 
degradation kinetics within the first 20 min of exposure with a loss of nearly 40 % of the ASX 
content, followed by a slower rate of degradation until the end of the experiment with the 
retainment of only 5.6% ASX after 24 h. The WPC ASX NPs sample showed a slower decrease of 
ASX compared to the former. Indeed, after 20 minutes the amount of ASX retained was 95.4%. 
After 24 hours the amount of ASX was 31.1%. The results show a protective effect of the WPC 
protein shell towards Fe3+-mediated degradation.  
 
 





3.2.4. Thermal stability 
Schall oven test (Slater, 1984) is regularly applied to study the stability of lipophilic substances 
such as edible oils. This test was employed to study the thermal stability of WPC ASX NPs and 
H.p. oleoresin. The samples displayed similar ASX degradation rates (Fig. 9), with H.p. oleoresin 
characterized by a slightly higher stability until the 4th day. After this period an inversion of the 
degradation rates was observed. To further analyze the data obtained, first order kinetics equation 
was applied to describe the degradation kinetics of ASX (Fig. 10). This fit was chosen because 
already described for the degradation of ASX and other carotenoids (Vakarelova et al., 2017; Lim, 
Burdikova, Sheehan, & Roos, 2016;Villalobos-Castillejos, Cerezal-Mezquita, Hernández-De Jesús, 





A straight line was found from the fitting on the data obtained from WPC ASX NPs describing a 
first order degradation kinetics. Different was the result obtained with H.p. oleoresin: while until the 
4th day a straight line was obtained from the plot, after this period an acceleration of the degradation 
rate was observed.  
 






The quicker degradation of H.p. oleoresin could derive from the absence of the protective glassy 
matrix present in the NPs system that allows for a faster accumulation of reactive degradation 
species (Boon et al., 2010; Takeungwongtrakul & Benjakul, 2016) originating from the oxidation. 
When these degradation species reach a certain concentration they could further oxidize the 
carotenoids present in H.p. oleoresin. 
A gradual loss of color was observed for both the samples. As reported previously the auto-
oxidation products of carotenoids do not present color properties due to the lack of chromophores at 
the absorption wavelength of visible light (Wagner & Warthesen, 1995; Villalobos-Castillejos et 
al., 2013). HPLC analyses of ASX extracted from WPC ASX NPs and the H.p. oleoresin underline 
the lack of a selective degradation of ASX: indeed, losses were observed for all the compounds 
present in the encapsulated H.p. oleoresin (data not shown). The absence of new peaks detected at 
480 nm suggest the conversion of carotenoids in non-carotenoid products. It is reported that the 
thermal degradation of carotenoids in the presence of oxygen results in the formation of volatile 
compounds and larger non-volatile compounds (Bonnie & Choo, 1999). The scarce protection of 
WPC shell against temperature could be due to the high surface exposed of the NPs, that could lead 
to a major exposure of ASX to heat and as a consequence to the degradation of the ASX carbons 
chain.  





3.2.5. Evaluation of bioaccessibility by simulated digestion 
The absorption of carotenoids during digestion occurs mainly in the first part of intestine, where the 
uptake through the intestinal mucosa takes place (Chitchumroonchokchai & Failla, 2006; 
Desmarchelier & Borel, 2017).  
The amount of ASX released, and thus bioaccessible, from NPs after the gastric phase was about 
45% (Fig. 11). This release can be explained considering that during this phase an evident 
aggregation of the NPs was observable probably as a consequence of the low pH value close to the 
pI of the whey proteins.  
During the intestinal phase the aggregates disappeared. This is confirmed also by the average size of 
the particles 165.5 nm and a PDI of 0.290. The release of ASX reached about 65 % after 2 hours of 
intestinal digestion, that, in this model, represents the small intestine (Versantvoort, Oomen, de 
Kamp, Rompelberg, & Sips, 2005; Kopf-Bolanz et al., 2012). After 4 hours of intestinal digestion 





Fig.11. Release of ASX from WPC ASX NPs during in-vitro simulated digestion. p<0.05. 
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To evaluate the contribution of the buffer conditions to ASX release observed, a second SD in 
absence of digestive enzymes was performed. As shown in Fig.11 the incubation of the NPs with 
the simulant buffers produced a fast release of ASX (35,7%) in the gastric medium, not far from the 
45% release shown in Fig. 11 at the same time point. This means that almost 80% of the released 
ASX was due to the acidic conditions that probably denatured partially the structure of the NPs, 
causing the release of the carotenoid. Note worthily, no ASX was released during intestinal phase in 
absence of enzymes, indicating that probably NPs structure was somehow restored (Fig.12). Hence 




The simulated digestion (SD) was performed not only to address the bioaccessibility of the 
encapsulated ASX but also to evaluate possible chemical modifications of the carotenoid. HPLC 
analysis of the oleoresin extracted from NPs collected before and after digestion could give a 
picture of the variation of the esterification degree of ASX. Fig. 13 shows that the esters 
composition before digestion was mainly represented by monoesters and diesters, accounting on the 
whole for the 99% of the ASX present, while after two hours of the intestinal digestion the major 
form was represented by free ASX (66%). After 4 hr of digestion the conversion to the free form 
reached 75%. This result is of great importance because the de-esterification of carotenoids is a 
crucial step required for their uptake through the intestinal mucosa.  
Montero and co-workers (2016) observed only 20% of total ASX in the free form upon digestion of 
a microencapsulated ASX system constituted of a gum arabic shell. The lower de-esterification 
experienced can be explained considering different factors: 1) the difference in the matrix 




composition (whey protein vs gum arabic), 2) the oleoresin: matrix ratio [1:1 in our case, 1:10 in 
Montero et al. (2016)], and 3) the difference in surface to volume ratio, that in our case is higher 
being the particles diameter in the nano-range while the particles diameter described by Montero et 









Fig.13. Concentration of the different chemical forms of ASX: free form, monoesters and diesters of ASX before 






In the present work ASX oleoresin obtained from H.p., was successfully nano-encapsulated through 
emulsion solvent-evaporation technique. This allowed to disperse a strongly hydrophobic molecule 
like astaxanthin in water maintaining the light absorption characteristics of the carotenoid. In this 
work we described the optimization of different parameters to identify the conditions leading to best 
compromise between the lowest achievable diameter, the highest stability and the greatest payload. 
In particular, besides a scarce solubility in the pH range of 3.5-5.5, the NPs obtained showed a 
higher stability toward UV light, metal-induced oxidation and heat degradation with respect to the 
oleoresin. Simulated digestion of NPs showed a high ASX bioaccessibility (90%) with 75% 
conversion to the free form that represents the most bioavailable ASX form. The formulation can be 
considered a good candidate carrier for the delivery of high amounts of ready-to-absorb astaxanthin 
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Chapter 3.  
Evaluation of different plants proteins for the          
nano-encapsulation of H.p. oleoresin 
 
Abstract  
The aim of this study was to research for plant alternative proteins as encapsulating matrices for 
astaxanthin in order to satisfy the increasing interest of the consumers for substitutes of animal-
deriving ingredients. Astaxanthin (ASX), a ketocarotenoid with high antioxidant activity, was nano-
encapsulated using soya protein isolate (SPI), pea protein isolate (PPI) and rice protein isolate (RPI) 
through emulsion-solvent-evaporation method. While by SPI and PPI it was possible to obtain 
nanoparticles (NPs) with diameters between 80-200 nm on average, and high encapsulation 
efficiency (EE), RPI did not allow to obtain positive results, since most of the ASX was not 
encapsulated, probably due to the scarce emulsifying properties of RPI. To further optimize the 
process, SPI and PPI proteins were subjected to different heat and pH treatments prior 
encapsulation. The results were analyzed on the basis of mean particle size, polydispersity index 
(PDI), Z-potential, encapsulation efficiency (EE) and presence/absence of ASX exposed on the 
surface of the NPs. The pre-treatments did not influence substantially the encapsulation efficacy of 
the proteins. The release of ASX in simulated digestive fluids from SPI and PPI NPs was compared 
to that of WPC NPs disclosed in the chapter 2. 












The enrichment of foods with lipophilic bioactive components, such as phytosterols, carotenoids 
and omega 3 fatty acids, is a growing area in the food industry (McClements, 2010). Nano-
encapsulation, referred to the production of encapsulates with dimensions in the range of 1-100 nm, 
seems to be the most suitable approach to increase the scarce bioavailability of lipophilic 
components and to avoid substantial modification of the sensory and rheological profiles of the 
enriched products (Augustin & Hemar, 2009; L. Chen, Remondetto, & Subirade, 2006). Among the 
different systems (e.g. solid lipid nanocarriers and liposomes) emulsion-based technologies are 
particularly suitable for the design and fabrication of delivery systems for bioactive lipids, thanks to 
their high stability, aqueous solubility, enhanced bioavailability and an ease of processing with high 
monitoring possibilities of particle size, depending on the technology employed (MacAdam, Shafi, 
James, Marriott, & Martin, 1997; Kakran & Antipina, 2014; Lu, Kelly, & Miao, 2016). Solvent-
evaporation is one of the most popular encapsulating methods. By this technique, nanoparticles 
(NPs) are produced through the use of emulsifiers such as globular proteins (e.g. whey proteins, 
sodium caseinate, soy proteins, etc.) that thanks to their structure, flexibility and amphiphilic nature, 
rapidly adsorb to the emulsion surface, where they self-aggregate and form continuous and 
homogeneous membranes around oil droplets constituted by the lipophilic molecules dissolved in 
an organic solvent (Dickinson, 1994; Hu, McClements, & Decker, 2003; Lefèvre & Subirade, 2003). 
Proteins can also stabilize the formed emulsion due to the superficial charge (negative or positive) 
that they are able to impart to the droplets surface at pH above and below their isoelectric point (pI). 
This surface charge reduces the tendency to coalesce and flocculate. Another fundamental 
parameter is the crystallization of the lipidic molecules in the NPs core, that is caused by the 
evaporation of the solvent (Chu, Ichikawa, Kanafusa, & Nakajima, 2007).  
Astaxanthin (ASX) is a ketocarotenoid, belonging to a group of oxygenated carotenoids termed 
xanthophylls (Higuera-Ciapara, Félix-Valenzuela, & Goycoolea, 2006). Due to the high presence 
of conjugated carbon-carbon double bonds and of hydroxyl and ketonic groups at both the end of 
the molecule, astaxanthin displays a unique antioxidant activity (Chen, Lin, & Hsieh, 2007; Ambati, 
Siew Moi, Ravi, & Aswathanarayana, 2014; Rodríguez-Sáiz, de la Fuente, & Barredo, 2010; Rao et 
al., 2013). The successful use of ASX was reported in the treatment of cardiovascular diseases, 
different types of cancer, diabetes and neurodegenerative disorders (Guerin, Huntley, & Olaizola, 
2003; Fassett & Coombes, 2011; Pashkow, Watumull, & Campbell, 2008; Zhang, Leng, Zhang, & 
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Li, 2009; Palozza et al., 2009). However, its use in the food industry is limited because of its 
unsaturated nature, that causes extreme instability when the molecules is exposed to environmental 
stresses such as light, extreme pH, oxygen and heat (Vakarelova et al., 2017; Zhao et al., 2006). 
Furthermore, its low solubility in aqueous-based systems (such as the one present in the digestive 
system) causes a low absorption rate and consequently, low bioavailability (Tan & Nakajima, 2005; 
Anarjan et al. 2012). 
As previously described in chapter 2, ASX can be successfully encapsulated through emulsion-
solvent evaporation technique using whey protein as the emulsifier/stabilizer. Protein concentrates 
and isolates used in food industry are mostly derived from whey, soybean and wheat, but because of 
dietary restrictions and novel trends, food manufactures and consumers are looking for alternative 
proteins sources. Many plant proteins have been extensively studied in recent years, because of their 
biodegradable and renewable character and good functional properties, such as emulsifying, film 
forming capacity and water solubility (Euston, Al-Bakkush, & Campbell, 2009; Ducel, Richard, 
Saulnier, Popineau, & Boury, 2004). Furthermore, in recent years, health-promoting biological 
activities and regulatory functions have been associated to several proteins of plant origin (e.g. 
cardiovascular and bone health, inflammation, cancer prevention, weight control, insulin sensitivity 
and mineral absorption) (Carbonaro, Maselli, & Nucara, 2015). Proteins from soybean, pea, wheat, 
corn and barley have already proved their ability to protect sensitive bioactive substances and 
flavors thanks to their similar behavior in terms of emulsifying, chemical and gelling properties to 
those of whey protein. This was achieved through micro-encapsulation, mainly using spray-drying 
technique (Fernandez-Avila, Arranz, Guri, Trujillo, & Corredig, 2016; Ducel et al., 2004; Charve 
& Reineccius, 2009). However, plant proteins have rarely been reported as nano-encapsulation 
matrices (Yi, Lam, Yokoyama, Cheng, & Zhong, 2015; Fernandez-Avila et al., 2016).  
The aim of this study was to evaluate the properties of some commercial proteins isolated from soy, 
pea and rice, for the nano-encapsulation of ASX. Size, stability, encapsulation efficiency and the 
presence of ASX on the NPs surface were analyzed. The release of ASX from the different NPs 
during simulated digestion was evaluated in comparison to that of the NPs developed using whey 







2. Material and methods 
2.1. Chemical and reagents 
Soya protein isolate (SPI) was purchased from ACEF (Milano, Italy). The protein composition 
(w:w) was protein 80%. Pea protein isolate (PPI) and rice protein isolate (RPI) were purchased from 
Raab Vitalfood (Rohrbach, Germany). PPI protein composition was 80% (w/w). RPI protein 
composition was 80% (w/w). Haematococcus pluvialis powder was purchased from a local supplier 
(Italy). Ethyl acetate, acetone HPLC-grade, pepsin, pancreatin, trypsin and sodium cholate were 
purchased from Sigma-Aldrich (St. Louis, MO, USA).  
 
2.2.  Astaxanthin extraction from H.p.  
H.p. oleoresin was obtained using the protocol proposed by Bustos-Garza and co-workers with 
minor modifications (Bustos-Garza, Yáñez-Fernández, & Barragán-Huerta, 2013). Briefly, the 
algae powder were pretreated by mixing 5 g of algae and 1 ml of 3 M HCl and treating the sample 
in a microwave oven for 1 min at 100 W (Sarada, Vidhyavathi, Usha, & Ravishankar, 2006). The 
pretreated algae were extracted with 25 ml of ethyl acetate in a tube with a screw cap, for 60 min 
under agitation at 50 °C in a thermal bath. The solid portion was separated by centrifugation at 3000 
g for 10 min to eliminate the biomass. The oleoresin was kept in the dark at 4 °C until use. 
 
2.3. Spectrophotometric analysis 
Quantification of ASX was performed using a UV/VIS spectrophotometer (Unicam UV2). The 
samples were diluted in ethyl acetate and the absorbance measured at 480 nm. The concentration of 
ASX was calculated following the equation: 
  
Where [A] is the concentration of ASX expressed as mg/ml; A480 the sample’s absorbance at 480 
nm; DF: dilution factor; E(1%;1cm): ASX percent solution extinction coefficient [(g/100 ml)-1 cm-1] in 




2.4. Astaxanthin nanoparticles preparation 
Astaxanthin nanoparticles (ASX NPs) were produced following the method described previously by 
(Yi et al., 2015) with some modifications.  SPI and PPI were dissolved in distilled water in a 
concentration range between 1 and 15%. The solution was stirred for 30 minutes at room 
temperature. H.p. extract was differently diluted in ethyl acetate and combined with the protein 
solution at a ratio of 9:1 (protein solution:oleoresin). A fine emulsion was produced using an ultra-
sonicator for 10 minutes at a potency of 10 W (Microson ultrasonic cell distruptor XL). At the end 
of the process ethyl acetate was removed using a nitrogen flow in the dark. The WPC ASX NPs 
were kept in the dark at 4 °C until use.  In the case of encapsulation with pre-treated protein: the 
proteins solution (1.0% w/w) used for encapsulation were prepared in three different ways 1) the pH 
of the aqueous solution was adjusted at 8 with NaOH 2 M; 2) Heat treatment at 80°C for 1 minute; 
3) combination of 1) and 2). As control, proteins dissolved in demineralized water were used. The 
solution was stirred for 30 minutes at room temperature. H.p. oleoresin was diluted in ethyl acetate 
at a final concentration of 2.5% and combined with the protein solution at a ratio of 9:1 for the 
production of the emulsion (protein solution:oleoresin).  
 
2.5. Characterization of astaxanthin nanoparticles 
2.5.1. Surface charge and average diameter  
Zeta-potential, mean diameter and polydispersity index (PDI) of NPs were analyzed by dynamic 
light scattering (DLS) principles using a Malvern Zetasizer (Nano-ZS; Malvern Instruments, 
Worcestershire, U.K). Before the analysis the sample were diluted 80 times to avoid multiple 
scattering effect. PDI value ranging from 0 to 1, indicated the distributions of the particle sizes, 
value close to 0 indicated a uniform population of particles and a value close to 1 indicated a wide 
variety of dimensions among particles size distribution. Zeta potential give an important 
information about particles stability, for values closer to 0 the system is considered not stable, due 






2.5.2. Superficial astaxanthin 
A volume of 0.5 ml of NPs was extracted with 1 ml of ethyl acetate by continuous agitation for 10 
minutes. The sample was centrifuged at 12.000 rpm for 5 minutes. The supernatant was collected, 
diluted and analyzed by a spectrophotometer as previously described. 
   
2.5.3. Simulated in vitro digestion 
In vitro digestion was performed following Infogest protocol (Minekus, Alminger, Alvito,, Ballance, 
Bohn, Bourlieu, ... & Dufour, 2014). Simulated gastric fluids (SGF) and simulated intestinal fluids 
(SIF) were prepared following the protocol. The duration of the two phases were 1 h for the gastric 
and 4 h for the intestinal phase. The enzyme used were pepsin for the gastric stage and pancreatin 
for the intestinal phase. Bile salts in the form of sodium cholate were added to SIF to a final 
concentration of 10 mM. Briefly. NPs and SGF were mixed in a ratio 1:1, the pH was adjusted to 3 
with HCl 1M. After 1 hour, SIF was added in a ratio 1:1 and the pH adjusted to 7 with NaOH 1M. 
The reaction was conducted at 37°C in a rotating shaker. At different time points samples were 
extracted with a double volume of ethyl acetate. The amount of ASX released from WPC ASX NPs 
were evaluated by spectrophotometry.  
 
2.6. Statistical analysis 
All measurements were performed at least three times and the results were reported as mean value ± 











3. Results and discussion  
SPI, PPI and RPI were employed as alternative encapsulant matrices to improve the water-
dispersibility and bioavailability of ASX through emulsion-solvent evaporation technique. Plant 
proteins are often better accepted by consumers since they can comply with specific cultural and 
religious indications, i.e. vegetarian, vegan, lactose-free and kosher. In addition, in compliance with 
the EU regulation (Annex II of the EU Food Information for Consumers Regulation No.1169/2011 
and Commission Delegated Regulation (EU) No. 78/2014 amending Annex II to Regulation (EU) 
No 1169/2011), pea and rice proteins are not considered as allergenic sources. 
 
3.1. Production of SPI and PPI ASX NPs  
Using the same approach described in chapter 2 the optimization of the encapsulation parameters 
for SPI and PPI started from the study of the variation of dimensions and z-potential of the NPs as a 
function of the concentration of protein and H.p. oleoresin. The first parameter considered, i.e. the 
concentration of proteins needed to encapsulate ASX, is crucial since the presence of free 
unabsorbed protein molecules in the continuous phase may promote depletion and flocculation of 
oil droplets (Dickinson & Golding, 1997) or the formation of unabsorbed proteins aggregates 
(Dickinson, 1994).  
 
3.1.1. ASX SPI NPs 
SPI are currently one of the most abundant plant proteins. They exhibit high nutritional value and 
desirable functional properties as emulsifiers and texturizing agents (Teng, Luo, & Wang, 2012). 
From the chemical point of view they are composed by a balanced composition of polar, non-polar 
and charged amino acids, and thus they are able to incorporate molecules  with different chemical 
characteristics (Riche & Williams, 2010). The major fraction of SPI is composed by glycinin and β-
conglycinin.   
In the case of SPI ASX NPs production, differently from WPC, it was impossible to obtain NPs 
using solutions more concentrated than 5% due to the limited protein solubility (see Fig.1). Average 
size, PDI and zeta-potential were considered as reference parameters to evaluate the performances 
of the process. In the first experiment, all the NPs were produced keeping constant the amount of 







dimensions ranged from 103 to 200 nm, confirming the strong dependence of size on proteins  
concentration, and the tendency of plant proteins to give bigger NPs probably due to the higher 
interfacial tension given by the higher tendency of this proteins to bind water, increasing as a 
consequence also the viscosity of the solution (Keerati-u-rai & Corredig, 2010; Chu et al., 2007), 
A 
B 
Fig.1.Variation of size and PDI (A) and z-potential (B) as a consequence of the different protein concentrations 




rigid structure (Yi, Lam, Yokoyama, Cheng, & Zhong, 2014), higher molecular weights (between 
200,000 and 350,000 Da) that renders the diffusion of proteins slower through the oil/ water 
interface (O’Sullivan, Murray, Flynn, & Norton, 2016) and the lower presence of hydrophobic 
amino acids in comparison to dairy proteins (Hu et al., 2003; Yi et al., 2015). PDI values were 
acceptable for all the formulations ranging from 0.24 (0.1% SPI) to 0.25 (5% SPI), describing 
moderate polydisperse samples. As already mentioned, zeta potential values higher than +20 and 
lower than -20 mV are good indicators of NPs stability (Müller, Jacobs, & Kayser, 2001), SPI ASX 
NPs displayed highly negative values for all the samples (Fig.1B), from -30 to -35.8 mV. The more 
negative values compared to those obtained with WPC, are due to the chemical structure of soy 
proteins and the higher presence of negatively charged groups at neutral pH. 
In order to evaluate the effect of H.p. oleoresin concentration on NPs production, SPI concentration 
was set to 1%. Differently from what described in chapter 2 using WPC, increasing concentrations 
of oleoresin led to the growth of NPs dimensions (Fig.2 A), from 83 nm using 1% oleoresin to 125 
nm with 4.5% oleoresin. Increasing further the concentration of oleoresin resulted in an unexpected 
decrease of the diameter. PDI values were in the range of 0.23-0.28. Like in the case of WPC, no 
particular trends could be appreciated, and no correlation of PDI to the diameter was found. The 
sample at 1% oleoresin gave the less negative Z-potential value (-19.7 mV) (Fig.2 B). This last 
result could be explained taking into account that a specific ratio between the protein acting as 

















Probably, in the case of the sample composed by 1% proteins and 1% H.p. oleoresin, the amount of 
proteins was too much higher in comparison to the oleoresin.  
The interaction of this free protein fraction together with the neo-produced NPs could result in a 
partition neutralization of the superficial charge, thus explaining the low Z-potential for this sample. 
Another phenomenon described in literature is that non absorbed stabilizer can also 
aggregate/flocculate, and probably interact with the NPs surface.  
With the increased amount of H.p. oleoresin, the decrease of the ratio protein/oleoresin could allow 
for the migration of the proteins to the oil droplet surfaces, producing the higher charge measured 
for these samples (Yerramilli, Longmore, & Ghosh, 2017).  
It must be noted that the results concerning the average size of the NPs here obtained are very 
different from those obtained by Yi e co-workers (2015), that using the same carrier system 
obtained β-carotene SPI NPs with an average diameter of 372 nm. This difference can be a 
consequence of the different molecular structure of the active ingredients encapsulated. Another 
important difference was that in our case the NPs were produced only with sonication while Yi and 
co-workers used a high pressure homogenization approach a 700 bar. Probably, the two methods 
have differently affected SPI characteristics (O’Sullivan et al., 2016).  
Fig.2 Variation of size and PDI (A) and z-potential (B) as a function of the different H.p. oleoresin concentrations 




The ASX SPI NPs obtained (Fig.3) were characterized by a red-orange color and a slight 
opalescence, especially at high protein concentration (Fig. 3 A). Opalescence in this type of system 
can arise from the presence of particles characterized by high particle size (higher than 100 nm) or 










3.1.2. ASX  PPI NPs 
The same analyses were conducted also for the nanoencapsulation of ASX using PPI as encapsulant 
matrix. The main fraction of PPI is composed by legumin (60,000 Da), vicilin (50,000 Da) and 
convicilin (70,000). As in the case of SPI, the percentage of protein concentration tested was from 
0.1 to 5% due to the fact that higher protein concentrations led to the production of a very viscous 
solutions not suitable for our purpose. As shown in Fig.4 A, the average diameter of ASX PPI NPs 
obtained ranged from 94 to 130 nm, with the NPs characterized by bigger dimensions produced 
respectively with the 0.1 and 5% protein concentrations. Z-potential ranged from -29.9 to -24.4 mV, 
underlying that all the NPs produced were characterized by a highly negative charge, and thus 
stability against flocculation and aggregation phenomena (Fig.4 B). No correlation was found 
between protein concentration and Z-potential. Keeping protein concentration constant (1%), by 
increasing the amount of H.p. oleoresin the dimensions of the obtained ASX PPI NPs ranged from 
100 to 140 nm (Fig.5 A), where the dimension of the NPs produced was correlated to the % of 
oleoresin, confirming the trend already observed in the case of ASX SPI NPs.  
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Fig.4. Variation of size and PDI (A) and z-potential (B) as a consequence of the different protein concentrations 
used to produce ASX PPI NPs. Differences between values indicated by the same letter are statistically significant 










Fig.5. Variation of size and PDI (A) and z-potential (B) as a consequence of the different H.p. oleoresin 
concentrations used to produce ASX PPI NPs. Differences between values indicated by the same letter are 




The PDI was comprised between 0.21 and 0.25 for the preparation containing H.p. oleoresin from 1 
to 5%, meanwhile the NPs produced with 7% of H.p. oleoresin showed a higher PDI, i.e. 0.257, that 
can be still considered associated to a moderate polydisperse system. For the NPs produced with the 
highest concentration of H.p. oleoresin (9 and 10%) a significantly lower PDI was unsuspectedly 
observed (i.e. 0.19). The lower protein to oleoresin ratio of these samples produced a more 
homogeneous NP population with bigger average size. The surface charge was highly negative for 
all the samples, from -27.7 to -31.9 mV (Fig.5 B), without an evident dependency on the amount of 
H.p. oleoresin. 
 
3.2. Evaluation of plant proteins encapsulation properties  
Commercial proteins isolates are commonly used as emulsifier in emulsification-solvent 
evaporation technique but sometimes they show poor solubility in the aqueous phase compared to 
the laboratory purified proteins (Donsì, Senatore, Huang, & Ferrari, 2010; Avramenko, Low, & 
Nickerson, 2013; Liang & Tang, 2013; Shi et al.,2015; Fernandez-Avila et al., 2016) thus limiting 
the possibility to further scale-up the process. A typical problem associated to isolates is the 
possible incomplete dissolution of the matrix that could generate the production of big particles and 
agglomerates, hampering the efficiency of the process. For this reason, we decided to study the 
encapsulation properties of proteins subjected to different pre-treatments: heat treatment, 
adjustment of pH to values far from isoelectric points of the proteins, and the combination of these 
two parameters. It is known that globular proteins may denature, dissociate and aggregate under 
different conditions of pH, ionic strength and temperature (Chen et al., 2006). For example, thermal 
treatment could lead to the unfolding of polypeptide chains followed by re-aggregation with 
concomitant exposure by the new formed complex of initially buried hydrophobic amino acid 
residues (Utsumi & Kisella, 1984). Such complexes can have different functional properties and 
digestibility (Duodu, Taylor, Belton, & Hamaker, 2003). 
 
3.2.1. SPI 
Comparative tests were performed in order to understand if the pre-treatments (heat, pH and a 
combination of the two) of proteins before encapsulation could have an effect on their solubility, 
and as a consequence, on the encapsulation efficiency of ASX. Fig.6 shows the obtained ASX SPI 











The smallest diameter was obtained with the non-treated proteins (N) i.e., 135 nm, the biggest 
diameter with the proteins solubilized at pH 8, i.e. 164.6 nm (Fig.7A). PDI values were in the range 
of 0.22 and 0.26 for all the preparations. Z-potential values (Fig.7B) were highly negative for all the 







ASX SPI NPs 














In Table 1 two significant parameters for the evaluation of the encapsulation process are reported: 
the encapsulation efficiency (EE), referred to the amount of ASX effectively encapsulated inside the 
NPs, and the superficial ASX (sASX), that describes the amount of ASX present on the NPs 
surface. sASX could easily undergo oxidation reactions losing its structural integrity and 








The EE was high for all the samples, with the highest value of 99% obtained for the heat-treated 
sample. The lowest values were obtained for the sample N with an EE of 93%, a value very similar 
to the one obtained by Yi and co-workers 2015. The higher EE displayed by sample H could be a 
ASX SPI NPs EE% sASX % 
Non-treated 93±0.01abc 0.0037±0.0001AB 
Heat 99±1.03a 0.0097±0.0004C 
pH 99±0.85b 0.0261±0.0023AC 
pH + heat 96±0.14c 0.0153±0.0004B 
Tab.1. Effects of the pretreatments on encapsulation efficiency (EE%) and superficial ASX % of ASX SPI NPs. 
Differences between values indicated by the same letter are statistically significant (P<0.05). 
Fig.7 Dependence of ASX SPI NPs size and PDI (A) and Z-potential (B) on the different protein treatments.  





consequence of the temperature-induced protein conformational changes that could allow to better 
allocate the oil phase (Wang, Li, Jiang, Qi & Zhou, 2014). The amount of superficial ASX was 
negligible for all the samples: from 0,026 to 0,0037%. Although the higher EE shown by the H 
samples the diameter of the particles was too big to be considered as satisfactory for our purpose. 
 
3.2.2. PPI 
The appearance of ASX PPI NPs is shown in Fig.6, The solutions were transparent and orange-red 







The average sizes of the obtained NPs (Fig.8A) were smaller than those obtained with SPI and 
much more similar to those obtained in chapter 3 with WPC. Sample H gave the NPs with the 
smallest average dimension (91 nm), pH and pH + heat treated samples gave the bigger NPs 
diameters (around 100 nm).  
 
Fig.8 Appearance of ASX PPI NPs produced with the differently treated proteins : H (Heat), N (non-treated), 












PDI values were very similar for all the samples, ranging from 0.25 to 0.265, underling that 
probably the pre-treatment of proteins did not have a considerable effect on the size distribution of 
ASX PPI NPs. Z-potential values were highly negative for all the samples (Fig.8 B), and no 
significant difference was observable between the samples. 
EE% ranged from 94-96%, with the lowest value exhibited by the sample N, and the highest by the 
sample H. Sample H displayed also the lowest amount of superficial ASX, 0.026%, and sample N 










ASX PPI NPs EE% sASX % 
Non-treated 94±2.6 0.033±0.0005 
Heat 96±0.5 0.027±0.0001 
pH 93±1.4 0.028±0.0012 
pH + heat 95±0.3 0.027±0.0003 
Tab.2. Effects of the pretreatments on encapsulation efficiency (EE%) and superficial ASX % of ASX PPI NPs 
 







With the goal of identifying novel non-allergenic and gluten free protein candidates we tried to 
employ also rice protein isolate (RPI). As shown in Fig.10, it was impossible to obtain ASX NPs 
with the use of this protein as emulsifier: large amounts of non-encapsulated ASX and opalescence 
were observed for all the samples, probably because of the presence of aggregated or non-
solubilized proteins. To our knowledge no data are reported in literature involving this type of 
matrix for nanoparticle production by emulsification-solvent evaporation technique. The works of 
Shi et al., 2015 and Shi et al., 2017 reported the ability of RPI to bind tea catechins, but this 
occurred only following pre-treatment and isolation of the soluble protein fraction of the rice bran, 
due to the high amount of fiber and fat. Therefore, in our study the absence of a purification step 
aiming at removing the non-soluble protein fraction, i.e. glutelins, could have negatively affected 
the process. This protein fraction is characterized by high presence of disulfide bond and high 
molecular weight. These characteristics make RPI a scarce emulsifier and thus not suitable for NPs 
production. Similar findings were discussed also in the work of O’Sullivan et al. 2016, who 
demonstrated that the use of ultrasonication was not able to reduce the size of RPI aggregates. In 
that case the presence of this insoluble aggregate was attributed to the occurrence of carbohydrates 
and to the denaturation of protein during the preparation of the isolate (Mujoo, Chandrashekar, & 







The obtained data suggest that SPI and PPI could be used for the production on NPs with 
satisfactory results in terms of small particle size, narrow PDI and stability to coalescence. In both 
cases, the pre-treatment of proteins by heating and/or adjusting the pH did not lead to a significance 
variation of the encapsulation performance. For this reason, in the following experiment we decided 
to avoid these treatments.  
   pH           pH+H              H                N 




3.3. Evaluation of ASX release by simulated digestion 
In vitro release of ASX from ASX SPI NPs and ASX PPI NPs, was assessed by simulated 
gastrointestinal digestion and the results were compared to ASX WPC NPs. These experimental 
data are important to study possible differences in the release profiles and thus in the 
bioaccessibility of encapsulated active molecule. Ideally, the release of ASX should occur in the 
intestine where absorption is supposed to take place. The time-dependent release of ASX is shown 
in Fig.11. At time 0 ASX release from ASX WPC NPs was the highest, accounting for 36% of the 
total amount. ASX SPI and PPI NPs showed similar patterns, with 22-23% release. This initial 
release for all the formulations could be due to the acidic conditions of the gastric medium (pH 3) 
that could destabilize the NPs structure. Liu and co-workers (2016) already observed aggregation 
phenomena of sodium caseinate nano-emulsions at pH 2, suggesting that some irreversible droplet 
aggregation occurred when the pH of the initial samples is adjusted from neutral to acidic condition 
(Liu, Chen, Cheng, & Selomulya, 2016).  
To further confirm this hypothesis, the average size of ASX PPI NPs was analyzed by microscopy 
and DLS (Fig.12), showing the formation of aggregates in the GS, a phenomenon already observed 
also by Overduin and coworkers, 2015. It was impossible to obtain information about the particles 
size due to the high PDI (>1) and presence of aggregates in the sample. At the end of the GS the 
release of ASX from ASX WPC and PPI NPs was comparable, i.e. 45% and 46 % respectively. 
Much higher was the release from ASX SPI NPs, that accounted for 80% of total ASX. For both 
Fig.11. ASX release from ASX WPC NPs, ASX SPI NPs and ASX PPI NPs during in-vitro simulated digestion. 
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ASX WPC and PPI NPs during the intestinal stage (IS) the release of ASX increased constantly 
within the first 3 hours except for the SPI formulation that, due to the large amount of ASX released 
during GS, showed a plateau after the first hour of IS reaching 99.7% release. At the end of the IS 





















Fig.12. Optical microscope image showing the agglomeration of ASX NPs during gastric stage (A) and 
(B) their disappearance in the intestinal stage. 
Gastric stage 




In this work three plant protein isolates from soy, pea and rice were tested as matrices for the nano-
encapsulation of ASX oleoresin from H.p, by emulsification-solvent evaporation method. SPI and 
PPI gave the best results allowing for the production of NPs with dimensions in the range of 90-130 
nm, while RPI where not suitable probably because of the low solubility and emulsifying properties 
of the proteins. Attempts aiming at optimizing the process for SPI and PPI revealed that neither the 
thermal pre-treatment nor the solubilization at pH far from the isoelectric point of the proteins 
before encapsulation, caused significant modifications of the encapsulation capacity of the matrices. 
The release profiles of ASX from SPI and PPI NPs were compared with the one of WPC NPs. WPC 
and PPI NPs displayed similar release patterns, while SPI NPs showed a burst release of most of all 
the ASX at the end of the gastric stage. Therefore, PPI seems to be the most suitable candidate as 
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Chapter 4.  
 
Antioxidant capacity of astaxanthin nanoparticles  
 
Abstract 
Astaxanthin (ASX) was enclosed through emulsion-solvent evaporation technology in a protein 
shell formed by whey protein (WPC). The antioxidant capacity (AOC) of the obtained nanoparticles 
(NPs) was characterized by colorimetric assay (ABTS) and by the development of a flow cytometry 
assay based on J774A.1 mice monocyte macrophages cell line aiming at evaluating the capacity of 
ASX to reduce chemically induced oxidative stress. Both the assays showed that WPC ASX NPs 
possess higher AOC compared to H.p. oleoresin. Confocal laser scanning microscopy (CLSM) and 
flow cytometry ware employed to gain more information about the cell uptake of NPs. The results 
showed that the transport mechanism was characterized by an energy-dependent model in Caco2 
and HepG2 cell lines. 
 
Key words: astaxanthin, nanoencapsulation, antioxidant activity, ABTS, cellular antioxidant 















Reactive oxygen/nitrogen species (ROS/RNS) are the products of normal metabolic respiration 
process. An excess of this species in the body could produce a damage of the DNA, proteins and 
lipids generating oxidative stress that can lead to cells death (Tandon, Sharma, Mahajan, & Bardi, 
2005). Oxidative stress is described as an imbalance between the production of radical species and 
the functionality of endogenous antioxidant protection systems (Sies, 1991; López-Alarcón & 
Denicola, 2013). ROS and RNS are not only dangerous, these molecules are important player in 
fundamental functions like cells signaling and biosynthetic reactions. However, a strong imbalance 
between the production of oxidative species is considered to have a role in the process of aging and 
several degenerative diseases, such as cancer, atherosclerosis and cardiovascular disease (Meagher 
& Rader, 2001; Storz,  2005). 
Carotenoids have been investigated due to their capability to act as ROS quencher in different 
biological systems. Among them, astaxanthin (ASX) (3,3’-dihydroxy-4,4’-dione-β,β’-carotene) 
showed strong antioxidant and anti-inflammatory properties (Liu, Mao, Zhou, & Guarnieri, 2016). 
Antioxidant activity of ASX was reported to be 10-100 times higher than vitamin E and β-carotene. 
ASX possesses also higher ability in the protection of lipids from photo-oxidation compared to 
lutein and β-carotene (Naguib, 2000; Kurashige, Okimasu, Inoue, & Utsumi 1990). With the 
growing perception of the consumer of a link between diet and human health, and the increasing 
tendency to consume supplements in order to enrich the diet, ASX due to its recognized multiple 
health effects and superior antioxidant activity has become one of the important health-promoting 
ingredients in functional foods and beverages. However ASX use is limited by its tendency to 
degrade at different conditions such as: light, presence of oxygen, extreme temperature and pH 
(Anarjan & Tan, 2013a; Tamjidi, Shahedi, Varshosaz, & Nasirpour, 2017; Bustos-Garza, Yáñez-
Fernández, & Barragán-Huerta, 2013). This characteristic led to search for new technologies 
aiming at the stabilization of ASX that in the last years produced different solutions, mainly in the 
field of nano- and micro-encapsulation. In particular, nano-particles containing ASX were 
developed in the past in the form of inclusion complex with β-cyclodextrin (Chen, Chen, Guo, Li, & 
Li, 2007; Yuan, Du, Jin, & Xu, 2013), liposome, solid lipid nanostructures (Tamjidi, Shahedi, 
Varshosaz, & Nasirpour, 2014), nano-emulsions with different mixture of proteins and 
polysaccharides (Anarjan & Tan, 2013b). Often these studies were focused only at the “design” of 
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the encapsulation process but very little is known about the behavior of the particles, their 
biological activity and toxicity in biological system.  
Chapters 2 and 3 described the production of ASX nanoparticles (ASX NPs) enveloped in a 
proteins shell. The present study focuses on the analysis of the antioxidant activity of ASX NPs 
through ABTS colorimetric assay. This method is recognized as simple, reproducible and sensitive 
but it does not allow to gain information about the direct effect of the antioxidant substance in a 
complex system, such as a cell. The use of cellular systems could allow to gain new data about the 
cellular uptake and the potential cytotoxicity of the developed nano-carrier. Indeed, although the 
NPs produced in the previous chapter are formed by a biodegradable and GRAS matrix, there are 
some concerns about the safety and potential toxicity of nano-carriers (Conner & Schmid, 2003). To 





















2. Material and methods 
 
2.1. Chemical and reagents 
Whey protein concentrate (WPC) was gently provided by I.T.A.L.I (Reggio-Emilia, Italy). Protein 
composition (w:w) was 80%. Haematococcus pluvialis powder was obtained from a local producer 
(Italy). Ethyl acetate, Fluorescein isothiocyanate (FITC), methanol, 2′,7′-Dichlorofluorescin 
diacetate (DCFH-DA), Dimethyl sulfoxide (DMSO), trypsin, 2,2′-Azino-bis(3-ethylbenzthiazoline-
6-sulfonic acid (ABTS), Potassium persulfate (PPS), Trolox were purchased from Sigma-Aldrich 
(St. Louis, MO, US).  
 
2.2. Astaxanthin extraction from H.p.  
H.p. oleoresin was obtained following the protocol proposed by Bustos-Garza and co-workers with 
minor modifications (Bustos-Garza et al., 2013). Briefly, the algae powder were pretreated by 
mixing 5 g of algae and 1 ml of 3 M HCl and treating the sample in a microwave oven for 1 min at 
100 W (Sarada, Vidhyavathi, Usha, & Ravishankar, 2006). The pretreated algae were extracted 
with 25 ml of ethyl acetate in a tube with a screw cap, for 60 min under agitation at 50 °C in a 
thermal bath. The solid portion was separated by centrifugation at 3000 g for 10 min to eliminate 
the biomass. The oleoresin was kept in the dark at 4 °C until use. 
 
2.3. Astaxanthin nanoparticles preparation 
Astaxanthin nanoparticles (ASX NPs) were produced following the method described previously by 
(Yi, Lam, Yokoyama, Cheng, & Zhong, 2015) with some modifications. WPC was dissolved in 
distilled water at concentrations of 1%. The solution was stirred for 30 min at room temperature 
without pH modification. ASX extract from H.p. in ethyl acetate were combined with the protein 
solution at a ratio of 9:1. A fine emulsion was produced using an ultra-sonicator for 10 min at a 
potency of 10 W (Microson ultrasonic cell distruptor XL). At the end of the process ethyl acetate 






2.4. Spectrophotometric analysis 
Quantification of ASX was performed using a UV/VIS spectrophotometer (Unicam UV2). The 
samples were diluted in ethyl acetate and the absorbance measured at 480 nm. The concentration of 
ASX was calculated following the equation: 
[A ]= 10 x A480 x DF
E(1 ;1 cm)x d  
 Where [A] is the concentration of ASX expressed as mg/ml; A480 the sample absorbance at 480 
nm; DF: dilution factor; E(1%;1cm): ASX percent solution extinction coefficient [(g/100 ml) -1 cm-1] 
in ethyl acetate (2150); d: the optical path (cm). 
 
2.5.  Surface charge and average diameter  
Zeta-potential, mean diameter and polydispersity index (PDI) of WPC-ASX nanoparticles were 
analyzed by dynamic light scattering (DLS) principles using a Malvern Zetasizer (Nano-ZS; 
Malvern Instruments, Worcestershire, U.K). Prior the analysis the sample were diluted 80 times to 
avoid multiple scattering effect. PDI value ranging from 0 to 1, indicated the distributions of the 
particle sizes, value close to 0 indicated a uniform population of particles and a value close to 1 
indicated a wide variety among particles dimensions. Zeta potential give an important information 
about particles stability, for values closer to 0 the system is considered not stable, due to the 
absence of a net charge that can contrast the aggregation process of NPs. The obtained results are 
the average of at least three measurements. 
 
2.6.  ABTS assay 
For ABTS assay we followed the procedure proposed by Thaipong and Co-workers, (2006) with 
some modifications. The working solution was prepared from a stock solution formed by 7.4 mM 
ABTS solution and 2.6 mM potassium persulfate (PPS) solution. The working solution was then 
prepared by mixing the two stock solutions in equal quantities and allowing them to react for 12 h at 
room temperature in the dark. The solution was then diluted opportunely with methanol (for the 
H.p. oleoresin), or PBS (for ASX NPs) to obtain an absorbance of 0.75 units at 734 nm. Fresh 
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ABTS solution was prepared for each assay. Samples (20 μl) were loaded in a 96-well plate and left 
to react with 180 μl of the ABTS solution for 2 h in a dark condition. Then the absorbance was 
taken at 734 nm using a plate reader. The standard curve was linear between 25 and 600 μM Trolox. 
Results were expressed in μM Trolox equivalents (TE)/g mass. Additional dilutions of the samples 
were eventually performed in order to fit the standard curve.  
 
2.7. Cell culture 
The experiments dealing with cells have been carried out in collaboration with the laboratory of 
animal cell cultures of the University of Verona directed by Prof. Roberto Chignola. The utilized 
cell lines were from ATCC (American Type Culture Collection Rockville, Maryland, USA).   
Monocyite macrophages cell line (J774A) from adult mice, HepG2 (human hepatocellular 
carcinoma, ATCC HB-8065, cell type: epithelial) and Caco2 (human colorectal adenocarcinoma, 
ATCC HT-B37, cell type: epithelial), were cultured in RPMI 1640 medium (Biochrom AG, Berlin, 
Germany) supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine (Sigma, St. Louis, 
MO., USA) and 35 mg/l of gentamycin. Cells were grown at 37°C in a humidified 5% CO2 
atmosphere in T75 culture flasks (Greiner Bio-One, Frickenhausen, Germany) and periodically 
were diluted with fresh medium to avoid starvation. The concentration of viable cell was measured 
by an haemocytometer in presence of trypan blue (0.1% in PBS, Biochrom AG).  
 
2.7.1. Cytotoxicity assay 
HepG2 cells were initially seeded in 96-wells culture plates at a density of 25000 cells in 200 μl of 
complete medium. After 6 h 25 μl of medium was removed and substituted with a same volume of 
antioxidant, and incubated for 30 minutes at 37°C. The antioxidant was represented by H.p. 
oleoresin dissolved in 1% DMSO and WPC ASX NPs both tested at the following concentrations: 
0.2, 0.1 and 0.05 mg/ml. Methanol 20% was used as negative control, RPMI medium as positive 
control and DMSO 1% to test if even in small quantity it could affect cell vitality. Cells were 
counted using light phase-contrast microscopy (Olympus IX51; Olympus, Tokyo, Japan), using a 
Burker chamber, and the vital dye trypan blue (dilution 1:2 v/v) to exclude dead cells. ATP was 
determined by the luciferine/luciferase method using CellTiter-Glo® Luminescent Cell Viability 
Assay Kit (Promega, Madison, WI, USA), following the manufacturer’s instructions. Emitted light 
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was measured using a microplate luminometer (FLx 800, Bio-tek Instruments) and data were 
expressed in luminescence arbitrary units. 
 
2.7.2.  Cellular antioxidant activity by flow cytometry 
Adult mice macrophages cell line J774A were seeded at a density of 1x105 cells in 2 ml of RPMI 
medium. After an incubation of 24 h at 37°C 1 ml of the medium was removed and 500 μl of 
DCFH-DA 50 μM and 500 μl of antioxidant were added. The tested antioxidants were: H.p. 
oleoresin dissolved in 1% DMSO and WPC ASX NPs dissolved in RPMI both at the concentration 
of 14, 7, 3.5, 1.75, 0.875 and 0.438 μg/ml of H.p. oleoresin. As a control, also the antioxidant 
activity of native WPC protein was analyzed at concentrations of 25, 12.5 and 6.25 μg/ml. After 
incubation with the antioxidant, the medium was removed and a same volume (500 μl) of the 
oxidant species was added to the plate (600 μM ABAP and 0.002% H2O2 were tested as different 
stressing conditions). The treated cells were incubated for 30 minutes at 37°C. After incubation the 
cells were scraped from the plate to obtain a cellular suspension for the cytofluorimetric analysis. 
The suspension was kept at 4°C until use. The cells associated fluorescence was measured using a 
Guava easyCyte TM 5 flow cytometer v.2.7 software (Merck Millipore, Billerica, MA, U.S). The 
cytometer was equipped with 488 nm, 20 mW, blue laser light, and forward scatter (FSC) 
photodiode and side scatter (SSC) photomultiplier. Green fluorescence 525/30 filter, yellow 583/26 
and red 680/30 filters allow analysis of fluorescence emissions from samples. Calibration of the 
cytometer was routinely checked using the Guava EasyCheck kit (Merck Millipore, Billerica, MA, 
U.S.) according to the manufacturer’s instructions. The raw data were exported, and then processed 
and analyzed by Mathematica software. 
 
2.7.3. Confocal microscopy 
The uptake of WPC ASX NPs was analyzed by confocal microscopy. To this purpose, WPC ASX 
NPs were labelled with fluorescein isothiocyanate (FITC). In particular, 10 mg of lyophilized WPC 
ASX NPs were resuspended in 1.695 μl of carbonate buffer pH 7.3. Ten milligrams of FITC was 
resuspended in 1 ml of DMSO. Eighty μl of FITC concentrated solution was added to the WPC 
ASX NPs solution and left to react for 2 h in the dark. The non-reacted FITC was removed using a 
PD Mini-Trap desalting column with Sephadex G-25 resin (Supelco, Bellefonte, PA, U.S.).  
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The following cell lines were used: Caco2 (human colorectal adenocarcinoma, ATCC HT-B37, cell 
type: epithelial), HepG2 (human hepatocellular carcinoma, ATCC HB-8065, cell type: epithelial). 
Cells were routinely cultured at 37 °C in a humidified 5% CO2 atmosphere, in RPMI 1640 
(Biochrom AG, Berlin, Germany) supplemented with 2 mM glutamine (Sigma-Aldrich, St.Louis, 
MO, USA), 35 mg/l gentamycin (Biochrom AG) and 10% heat-inactivated fetal bovine serum 
(Biochrom AG). Cells were seeded into the wells of glass bottom μ-Slide IbiTreat chambers (Ibidi 
GmBH, Martinsried, Germany) at the initial cell density of 5·104 cells/well in 200 µl complete 
growth medium and incubated for 24 hours at 37 ºC. A volume of 50 µl of FITC-labelled WPC 
ASX NPs solution (green fluorescence) was then added, and the cells were further incubated at 37 
ºC for 1 hour. Cells were carefully washed with PBS, fixed with 4% (w/v) paraformaldehyde for 30 
min and, after washings with PBS and quenching with 50 mM NH4Cl, permeabilized with PBS-
0.1% Triton X-100. Cells were then stained with rhodamine-phalloidin (to label F-actin, red 
fluorescence; Cytoskeleton, Denver, CO, USA) for 30 min and then with DAPI (to label nuclei, 
blue fluorescence; Sigma-Aldrich, St.Louis, MO, USA) for 10 min. Images at Δz=0.5 μm were 
collected using the SP5 confocal microscope from Leica Microsystems (Mannheim, Germany) with 
63x objective (HCX PL APO λ blue 1.4NA OIL). Image analyses were performed with ImageJ v. 
2.0.0 software. 
 
2.7.4. Cell nanoparticles uptake  
To gain information on the mechanism involved in the cellular uptake, the experiment was 
conducted in the presence of a blocking condition, i.e. at low temperature. Indeed, Caco2 and 
HepG2 cells were incubated with FITC-labelled WPC ASX NPs (0.02 mg/ml) at 4°C for 30 










3. Results and discussion 
ASX NPs were obtained through emulsion solvent-evaporation technique with whey protein 
concentrate as encapsulant matrix. The obtained particles, were stable in solution, characterized by 
a highly negative Z-potential value (-28.5 mV), an average diameter of 90-100 nm) and a low 
polydispersity index (PDI) (0.245), underlining the presence of a slightly polydisperse population of 
NPs.   
 
3.1.  Antioxidant capacity 
The antioxidant capacity of a given molecule can be attributed to different mechanisms which are 
for example the binding of transition metals, radical scavenging activity and, in the particular case 
of carotenoids, the possibility to quench radical species due to their highly unsaturated nature. In the 
case of ASX some works have suggested that its radical scavenging activity is mediated by the 
transfer of hydrogens or electrons, and in the case of the quenching of singlet oxygen, by energy 
transfer between the electrophilic singlet oxygen and the polyene chain (Zhang, Sun, Sun, Chen, & 
Chen, 2014).  
A concentration of 0.2 mg/ml of ASX from H.p. oleoresin was shown to have a Trolox Equivalent 
Antioxidant Capacity (TEAC) value of 30 (expressed as mmol Trolox/kg extract), between 6 and 9 
times lower than the values found in literature, probably because of the low extraction efficiency of 
ASX or for the differences in the algae batch used (Jaime et al., 2010; Cerón et al., 2006). WPC 
ASX NPs displayed an 11-folds higher antioxidant capacity than H.p. oleoresin tested at the same 
concentration. This result could be explained considering the antioxidant properties of whey 
proteins, already described in literature (Yi et al., 2015) and the small diameter of the NPs, if 
compared to the crystalline form of non-encapsulated H.p. oleoresin, that might increase the surface 
to volume ratio. The AOC of WPC native proteins were tested and found to contribute for the 
74.2% of the total WPC ASX NPs antioxidant capacity. This was probably due to the free radical 
scavenging activity properties of cysteine, tyrosine, tryptophan, phenylalanine and histidine 






3.2.  Cellular antioxidant activity of WPC ASX NPs 
The AOC of WPC ASX NPs was tested also through the use of model cell line. Initially, the 
cytotoxicity of H.p. oleoresin and WPC NPs were tested at three different concentrations (0.2, 0.1 
and 0.05 mg/ml) on HepG2 cells. The obtained results (Fig.1) showed negligible toxicity effect of 
WPC ASX NPs and a slight viability decrease of the cells treated with H.p. oleoresin at 0.1 mg/ml.  
 
 
Fig.1 Cell viability of HepG2 cells incubated at different concentrations of H.p. oleoresin,WPC ASX NPs and WPC 
NPs.  
 
Cellular antioxidant activity (CAA) was developed by Wolfe and co-workers (Wolfe & Liu, 2007). 
It is one of the most employed antioxidant techniques used to study the effect of antioxidant 
substances in cells systems in presence of highly reactive species. Although this technique is well 
established into microplate experimental set up using HepG2 cells, our attempts to apply this 
system to our samples did not lead to consistent and reproducible results (data not shown). For this 
reason, and because the method previously mentioned does not provide any information about cells 
viability during the experiments, a different approach based on flow cytometry was chosen. This 
approach gives the opportunity to discriminate between viable and non-viable cells due to their light 
forward and side scattering properties.  To perform the assay, a macrophages cell line from adult 
mice (J774A.1) was selected. Compared to HepG2, frequently employed for the CAA assay, 
J774A.1 cells present higher phagocytic activity and are easier to manipulate. Moreover, they are 
naturally capable to produce high amounts of ROS. The first step to develop the method was to 
identify an appropriate stimulus for the generation of ROS by the cells. Macrophages cells were 
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subjected to different treatments: thermal shock, and incubation with different chemicals, e.g. 
ABAP, H2O2. The generation of ROS would then oxidize DCFH-DA with the concomitant 
emission of green fluorescence. Among the treatments, as shown in Fig.2, the fluorescence 
distribution relative to the treatment with ABAP (Fig.2-B) and thermal shock (Fig.2-C) were close 
to the signal produced by the control sample (Fig.2-A). In the case of cells treated with H2O2 
(Fig.2.D) the fluorescence signal was largely increased in respect to the control, underlining a 
higher production of ROS species by these stressed cells. For this reason the treatment with H2O2 





As shown from the fluorescence data, in Fig.3-A WPC ASX NPs were able to inhibit the 
fluorescence emission in a dose-dependent manner more effectively than WPC alone in the form of 
native proteins and H.p. oleoresin. In particular, WPC ASX NPs showed an AOC respectively 4 
times higher than H.p. oleoresin at the maximum concentration tested (14 μg/ml) and 5 times higher 
than 1% WPC solution. It was interesting to observe that, differently from ABTS, by this system 
WPC did not show antioxidant properties, and all the activity seems to be related to ASX. The 
higher CAA showed by the nano-encapsulated system might derive from the higher uptake of ASX 





by the cells in respect of the H.p. oleoresin form. In this contest, another important point to 
underline is the fact that the dispersion of H.p. oleoresin solubilized in DMSO could have formed 
aggregate when in contact to aqueous media that had led to the formation of aggregate with larger 






Fig.3 Cellular antioxidant activity tested in adult mice macrophages cells (J774A.1) via flow cytometry with A) 
WPC ASX NPs, H.p. oleoresin and WPC and B) the comparison between the antioxidant properties of Trolox and 
WPC ASX NPs.  
A 
B 
0     4.5    9   13.5   18  22.5   27  31.5   36 
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In different study it was demonstrated that the bioavailability of encapsulated system is inversely 
proportional to the size, in part confirming the previous hypothesis (Salvia-Trujillo, Qian, Martín-
Belloso, & McClements, 2013; Wang et al., 2017). The antioxidant capacity of NPs was compared 
also with Trolox, as shown in Fig.3-B. ASX in the form of NPs showed higher antioxidant activity 
at all the tested concentrations. 
 
3.3.  Cellular uptake of WPC ASX NPs 
Testing the bioavailability of NPs by in vivo systems is difficult to perform from a practical and 
ethical point of view. In this way, in the last decade, in vitro models, such as cellular uptake 
analysis through confocal microscopy systems had gained much interest due to the fact that it can 
provide useful information about the potential fate of NPs in a complex system. It is also relatively 
easy, quick to perform, and it allows for relatively inexpensive screenings of multiple samples.  
 
 Fig.4 CLSM images of HepG2 and Caco2 cells incubated for different times with labelled FITC WPC ASX NPs.  
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In Fig.4 the micrograph pictures obtained by confocal microscope are observable. In particular, 
concerning HepG2 cells, WPC ASX NPs are visible inside the cells after 15 minutes of incubation 
underling that the uptake process of NPs is very fast, the accumulation seems to proceed later on 
during the first and the second hour of incubation as can be observed by the slight increase of 
fluorescence (Fig. 4).   
The cell uptake of NPs seems to follow a precise pattern showing a strong accumulation of NPs 
along actins filaments. Actin polymerization and rearrangement plays an important role during 
endocytic internalization, in particular in clathrin- and caveolae-mediated process (He et al., 2013). 
WPC ASX NPs uptake is visible also in Caco2 cells. NPs appear to accumulate close to the cell 
membrane leading to bigger aggregates after 2 hours. It was already reported that the higher 
presence of carboxylic groups and surface charge of protein NPs  correlate with an increased cell 
uptake (He et al., 2013; Gåserød, Jolliffe, Hampson, Dettmar, & Skjåk-Bræk, 1998). 
 
3.4. Inhibition study 
The cellular uptake of NPs with diameters around 100-150 nm has been already described in 
literature as endocytic internalization (Conner & Schmid, 2003). To confirm this kind of mechanism 
also in the case of WPC ASX NPs, the uptake was tested in presence of an endocytic blocking 
condition for both HepG2 and Caco2 cells. At 4°C, the condition tested, all the energy-dependent 
processes, and thus also endocytosis, are inhibited. In Fig.5 HepG2 cells showed a NPs uptake 
inhibition percentage of 86%, Caco2 cells showed an inhibition of 68%. The lower uptake could be 
due to the reduced cell activity and to the scarce fluidity of the cell membrane. The uptake still 
measured could be explained by the presence of residual ATP, that can be used for the 
transportation of the NPs in the cells. In particular, during endocytic internalization it was reported 
the polymerization and rearrangement of actin filaments when the process was caveolae- and 
clathrin- mediated, this seems to validate our previous observations about the peculiar positioning 










To obtain a deep understanding of the mechanism behind the uptake of WPC ASX NPs more 
investigation will be required, e.g. by using other blocking agents such as, genistein, that is reported 
to inhibit F-actin during internalization and clathrin-mediated uptake (Iversen, Skotland, & Sandvig, 
2011). Another possibility is represented by polarized cells, like those constituting the Caco2 
monolayer, which better resemble the complexity found in epithelial cell layers (Sandvig & van 
Deurs, 2005). 
 
Fig.5 Cellular uptake inhibition of WPC ASX NPs in presence of a blocking condition (4°C) in A) HepG2 and 







ASX NPs were characterized by a protein shell, a diameter around 100 nm and a negative surface 
charge. NPs showed a TEAC 11 times higher than ASX tested at the same concentration. WPC, the 
constituent of the membrane surrounding the oily core of oleoresin seemed to contribute for the 
70% to the total antioxidant capacity. The results of the cellular antioxidant activity were in 
agreement with ABTS confirming that WPC ASX NPs possess superior activity in comparison to 
non-encapsulated oleoresin. It is noteworthy that in this case the contribute of WPC to the total 
antioxidant capacity of WPC ASX NPs was definitely minor since in the form of native proteins 
they produced a strong fluorescent signal, proving their incapacity to counteract DCFH oxidation. 
These results confirm that the analysis in vitro of the antioxidant capacity of specific 
molecules/extracts should be confirmed by different approaches. The uptake by HepG2 and Caco2 
cells analyzed through confocal laser microscopy revealed peculiar mechanisms. Indeed, in the case 
of HepG2, the deposition of NPs along actin filament lead us to hypothesize the involvement of 
endocytic energy-dependent transport mechanism. The data obtained by the cellular uptake 
inhibition test confirmed a decreased uptake for both HepG2 and Caco2 cells in presence of an 
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Chapter 5.  
 
Conclusions 
In the present work the oleoresin extracted from Hametacoccus pluvialis was successfully nano-
encapsulated through emulsion solvent-evaporation technique using proteins as encapsulant 
material. This approach allowed to disperse in water a strongly hydrophobic molecule like 
astaxanthin maintaining the light absorption characteristics of the carotenoid in the visible 
spectrum. The process was optimized varying different parameters to identify the conditions leading 
to the best compromise between the lowest achievable diameter, the highest stability and the greater 
payload. In particular the size around 100 nm is the most crucial objective to achieve since this 
would improve the bioavailability of the encapsulated molecule. The use of ethyl acetate is merely 
of processing aid, since it is totally removed from the product after encapsulation and can be easily 
recovered and used for the subsequent production. Even though it is an organic solvent, ethyl 
acetate is characterized by low toxicity in comparison to dichloromethane that other authors 
employed for this type of encapsulating approach. Finally being largely used for other food 
processes it is not difficult to find food-grade forms of this solvent on the market. 
Form a technical point of view, the proposed protocol is easier in comparison to other works 
proposed in literature. Indeed satisfactory results were obtained without the need to 1) employ 
solvent-saturated water, 2) solubilize the proteins in buffered solutions 3) thermally pre-treat the 
proteins.  
The NPs produced with whey protein concentrate (WPC) showed a scarce solubility in the pH range 
of 3,5-5,5, that correspond to the isoelectric point of whey proteins. This problem could be solved 
including a coating step using polysaccharides gum arabic. However, NPs showed higher stability 
toward UV light, metal-induced oxidation and heat degradation with respect to the H.p. oleoresin. 
Simulated digestion of WPC NPs showed a very high ASX bioaccessibility (90%) with 75% 
conversion to the free form that represents the most bioavailable ASX form. NPs showed a higher 
antioxidant activity compared to H.p. oleoresin.  
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To study the antioxidant capacity of the NPs a flow-cytometry-based cellular assay was developed. 
Indeed, routinely used assays like ABTS do not take into account the complexity of a cell system 
that could help to understand for instance whether the NPs are toxic or are truly absorbed. The 
encapsulates showed higher antioxidant capacity in comparison to the oleoresin when analyzed both 
by ABTS and flow cytometry. The study of the uptake of the NPs in cell model systems through 
confocal laser microscopy and flow cytometry indicated that the process probably follows an 
energy-dependent mechanism. 
 
During the project we focused our attention in the research of further encapsulant matrices 
alternative to whey proteins in order to better comply with specific consumers cultural and religious 
needs, and/or in order to achieve an allergen-free ingredient. For this purpose, we selected three 
plant protein isolates from soy (SPI), pea (PPI) and rice (RPI). Out of these three matrices, SPI and 
PPI gave the best results allowing for the production of NPs with dimensions in the range of 90-130 
nm, while RPI did not lead to the production of NPs, probably because of the low solubility and 
emulsifying properties of proteins constituting the isolate.  
The release profiles of ASX from SPI and PPI NPs were compared with the ones of WPC NPs. 
WPC and PPI NPs displayed very similar release patterns, while SPI showed a burst release of most 
of the ASX at the end of the gastric stage. Therefore, PPI seems to be the most suitable candidate as 
plant alternative emulsifier for the production of ASX NPs. These results suggest that the use of 
different protein sources could allow to achieve a controlled release of the active ingredient, since 
specific molecules may need to be absorbed in different parts of the gastrointestinal tract.  
Taken together, all these results show that the developed nanoparticles can be considered a good 
candidate carrier for the delivery of high amounts of ready-to-absorb astaxanthin for human diet. 
ASX NPs could be applied in different markets, e.g.  the production of functional beverages, 
supplements in the forms of mono-dose sticks or sachets. To this purpose the formulations should 
be converted into more stable dried forms.  
 
 
 
